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Chapter 1:
Introduction
Eukaryotes regulate their genome locally, at single genes, and also globally at
the level of a large chromosomal domains. Dosage compensation is a good example of
global gene regulation. Many diploid species, such as round worms, dipterans and
mammals, determine sex with dimorphic chromosomes. Females and hermaphrodites
have two X chromosomes but males have single X and Y chromosomes (XY, diptera
and mammals) or no Y chromosome (XO, worms). The Y chromosome is gene poor,
and the genes present on it are expressed predominantly in male testicular tissue. The
X chromosome is thus hemizygous in males, creating an imbalance in X-linked gene
dosage between males and females. Different species have developed different
strategies to balance X-linked gene expression between the sexes, a process called
dosage compensation. In mammals, one of the X chromosomes of females is
inactivated to form the Barr body. X-linked gene expression from the active female X
chromosome equals that from the single X chromosome of males. In C. elegans,
hermaphrodites reduce the expression of both X chromosomes by half to equal
expression from the single male X chromosome. In contrast, Drosophila melanogaster
males increase expression from their single X chromosome to equal expression of the
two X chromosomes of females. This is accomplished by a complex of proteins and
RNAs called the Dosage Compensation Complex (DCC) or Male Specific Lethal (MSL)
complex (LARSSON and MELLER 2006).
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The MSL complex contains five proteins and two noncoding RNAs. These are
Male Specific Lethal 1, -2, and -3 (MSL1, -2, and -3), Maleless (MLE), Males absent on
the first (MOF) and the RNA on the X 1 and -2 RNAs (roX1 and roX2). All MSL proteins
and at least one roX RNA are necessary for dosage compensation. Mutations that
disable this system cause male lethality as third instar larvae or pupae, but females are
unaffected (LARSSON and MELLER 2006).
In our laboratory it was observed that roX RNAs are required for increased
expression of X-linked genes in Drosophila males (DENG and MELLER 2006).
Surprisingly, we also discovered that roX RNAs are involved in regulation of the 4th
chromosome in males, but not in females (DENG et al. 2009). This was unexpected
because the 4th chromosome is present in two copies in both sexes. The 4th
chromosome is also highly heterochromatic. After exhausting other possibilities, we
considered the idea that heterochromatic genes require roX RNA for full expression in
males. Interestingly, heterochromatic genes on the second and third chromosomes also
require roX RNAs for full expression (DENG et al. 2009).

The objective of my

dissertation is to understand the genetics and molecular mechanism of regulation of
autosomal heterochromatic genes by roX RNA and other MSL complex members. To
address this I pursued three specific aims.
What MSL proteins participate in normal expression of genes on the male
4th chromosome and in other heterochromatic regions?

To address this I

performed microarray analysis of msl2 mutant males and quantitative Reverse
Transcription Polymerase Chain Reaction (qRT-PCR) analysis of msl1 and msl3 mutant
males.

This is included in Chapter 3, along with my reanalysis of roX1 roX2
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microarrays. I found that MSL2 is unnecessary for full expression of heterochromatic
genes, and so the intact MSL complex is not involved. I have published this data in a
study on which I am co-first author (DENG et al. 2009). This study also revealed that
roX1 roX2 mutants are potent modifiers of Position Effect Variegation (PEV) in males,
but not females. This indicates that roX RNA is a general regulator of heterochromatin
in males. I subsequently performed qRT-PCR analysis of mof, mle and jil-1 mutants,
and these results are presented in Chapter 4.
What is the critical time for roX RNA regulation of heterochromatin? The
MSL proteins are not detected on the 4th chromosome or in heterochromatic regions of
polytene chromosome preparations of male third instar larvae, suggesting that these
molecules could act at these regions transiently, perhaps early in development. For
example, roX RNA and a subset of MSL proteins might be required during the
establishment of heterochromatin, which occurs around 3 hrs after egg laying (AEL). To
determine the critical time for roX and MSL regulation of heterochromatin, I developed a
genetic assay that takes advantage of PEV as an indicator of heterochromatic silencing.
The experimental system I used, which relied on a heat shock-induced roX1 expression
system, had technical limitations that prevented pinpointing of the critical time for roX
expression. However, it did reveal that the levels of roX necessary for dosage
compensation and heterochromatic silencing are dramatically different, suggesting that
these roles are genetically separable. This study is included in Chapter 4, a manuscript
in preparation.
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Are

specific

compensation

and

regions

of

roX1

differentially

heterochromatin?

The

required

observation

that

for

dosage

the

dosage

compensation and heterochromatic functions of roX1 could be partially separated
prompted me to ask if parts of the roX1 RNA were required for a single process. To
address this, I tested deletions of roX1 and mutated transgenes for restoration of PEV
and rescue of male survival. I discovered that both dosage compensation and PEV
require 5’ and 3’ elements of the roX1 transcript, but deletions in the central portion of
roX1 affect PEV, but not dosage compensation. This study is included in Chapter 4.
Do the MSL proteins involved in heterochromatic regulation bind to
chromatin of the regions that they control? The MSL complex binds to regulated
genes on the X chromosome (LARSCHAN et al. 2007). We postulate that a subcomplex,
composed of a subset of MSL proteins and roX RNA, might similarly bind the autosomal
regions

that

they

regulate.

To

address

this

question,

I

used

chromatin

immunoprecipitation (ChIP) to determine MSL3 localization at autosomal sites during
early embryogenesis.

MSL3 and MSL1 are required for full expression of

heterochromatic genes. MSL1 forms a scaffold for assembly of the MSL complex, and
we postulate that it may similarly organize a subcomplex necessary at male
heterochromatin. Embryos from MSL1 mutant females will lack this protein before
zygotic MSL1 expression commences at > 5 h AEL, and thus serve as a negative
control (RASTELLI et al. 1995). I demonstrated that MSL3 is enriched everywhere in
genome, regardless of chromosome or chromatin type, during early embryogenesis.
MSL3 enrichment is dependent on MSL1, thus fulfilling our prediction that a subcomplex
of MSL proteins can localize to chromatin. Zygotic expression of MSL1 after 5 h AEL
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largely restored MSL3 enrichment at autosomal locations, suggesting that binding of
these proteins persists several hours after the onset of dosage compensation at 3 h
AEL initiates recruitment the full MSL complex to the X chromosome.

My findings

reveal that the conventional picture of MSL proteins binding exclusively to X chromatin
does not reflect the situation in early embryos, and indeed may only be observed in
much older tissues.
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Chapter 2
roX RNAs and genome regulation in Drosophila melanogaster
This chapter has been published as a review: Koya, S. K. and Meller, V. H.
(2011). "roX RNAs and Genome Regulation in Drosophila Melanogaster." Prog Mol
Subcell Biol 51: 147-160. This review has been updated by the addition of recent
studies of relevance to my dissertation.
Abstract
Organisms with dimorphic sex chromosomes suffer a potentially lethal imbalance
in gene expression in one sex. Addressing this fundamental problem can be considered
the first, and most essential, aspect of sexual differentiation. In the model organisms
Drosophila, C. elegans and mouse, expression from X-linked genes is modulated by
selective recruitment of chromatin-modifying complexes to X chromatin. In both flies
and mammals, large non-coding RNAs have a central role in recruitment and activity of
these complexes. This review will summarize current knowledge of the function of the
non-coding roX genes in this process in Drosophila. Identification of an autosomal
function for the roX RNAs raises intriguing questions about the origin of the modern
dosage compensation system in flies.
Introduction
Genome regulation and large, non-coding RNAs
Control of gene expression is central to life in all organisms. In addition to local
gene regulation, many eukaryotes rely on coordinated control of large chromatin

7

domains. These clusters of co-regulated genes can be as large as an entire
chromosome. While the mechanisms that coordinate control of groups of genes are
often poorly understood, the frequent association of large, non-coding RNAs (lncRNAs)
with this process suggests that RNA is extremely well suited for regional chromatin
regulation.

The most dramatic example of this is sex chromosome dosage

compensation in flies and mammals.

Many diploid species, such as C. elegans,

Drosophila and mammals, have dimorphic sex chromosomes. Females and C. elegans
hermaphrodites have two X chromosomes, but males have a single X chromosome (XY
or XO). In these species the Y chromosome is gene poor, and the genes present on it
are expressed only in testes. The resulting imbalance in the ratio of X to autosomal
gene expression is potentially lethal to one sex (GUPTA et al. 2006; NGUYEN and
DISTECHE 2006). Several independently evolved strategies to balance X-linked gene
expression between the sexes, a process called dosage compensation, have arisen
(LUCCHESI et al. 2005). Drosophila males increase transcription from their single X
chromosome. This increase requires a transcript produced from the X-linked roX (RNA
on the X 1, - 2) genes. Mammalian females silence transcription from most genes on
one of their two X chromosomes.

Xist (X inactive specific transcript) is a lncRNA

produced from the X inactivation center (Xic) (reviewed by (PLATH et al. 2002; GONTAN
et al. 2011)). Production of Xist induces silencing of the X chromosome on which it is
situated of the two identical X chromosomes. In spite of striking differences in dosage
compensation between flies and mammals, both employ lncRNAs that regulate this
process and are necessary for identification of X chromatin.

This convergence of

function suggests that lncRNAs are particularly well suited to regulation of broad
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chromatin domains. This review will explore the regulatory role the roX transcripts in
Drosophila.
Non-coding RNAs in Drosophila:

a wealth of transcripts with few known

functions
The Drosophila melanogaster genome consists of over 16 thousand genes.
While only a few hundred are currently annotated as non-coding RNAs, this group is
poorly understood and annotations of non-coding transcripts lag the rest of the genome
(TWEEDIE et al. 2009). The best studied non-coding RNAs participate in translation, and
have well defined functions that are determined by the structure of the RNA in question.
But, in addition, there are numerous long, spliced and polyadenylated transcripts that
appear similar to mRNAs but lack significant open reading frames (TUPY et al. 2005).
Identification of these began over two decades ago, but just a handful of the predicted
lncRNAs in the fly genome have been studied in any detail. Of these, the roX RNAs are
perhaps the best understood. The potent regulatory effects of the roX genes raise the
question of whether some of the many transcripts with no known function may have
similar actions in genomic regulation.
roX RNAs and dosage compensation
To overcome the potentially lethal imbalance in gene expression caused by
hemizygosity of the X chromosome, male flies increase expression from almost all
genes on their single X chromosome. This ensures a constant ratio of X to autosomal
gene product in both sexes. To achieve this, a complex of protein and roX RNA, termed
the Male Specific Lethal complex (MSL complex or Dosage Compensation Complex,
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DCC), is recruited to the X chromosome with exquisite selectivity, as illustrated in Figure
2.1a and 2.1b. The MSL complex alters expression by modifying chromatin within the
body of transcribed genes. roX1 and roX2 are polyadenylated, non-coding RNAs that
are dissimilar in size and sequence (AMREIN and AXEL 1997; MELLER et al. 1997). The
major forms of roX1 are almost 4 kb, but the most abundant form of roX2 is only 500 bp
(AMREIN and AXEL 1997; MELLER et al. 1997; PARK et al. 2005). In spite of their dramatic
difference in size and sequence, roX1 and roX2 are redundant for all known functions.
Mutation of either roX gene alone has no phenotype, but simultaneous mutation of both
is male-lethal. Chromosome preparations from roX1 roX2 males display reduced X
localization of the proteins in the MSL complex, and these proteins now can be
observed binding at ectopic sites throughout the genome (Figure 2.1c). In contrast,
females mutated for both roX genes display no detectable phenotype and are fully
viable (MELLER and RATTNER 2002; DENG et al. 2009).
Although both roX genes are situated on the X chromosome, transcripts from
autosomal roX transgenes will assemble with the MSL complex, bind to the X
chromosome and rescue roX1 roX2 males (MELLER and RATTNER 2002). roX RNA can
therefore travel through the nucleoplasm to regulate a chromosome in trans to its site of
transcription. This suggests that the roX genes act in a fundamentally different way
than Xist, whose action appears limited to its chromosome of origin, a feature that
protects one X chromosome from inactivation. However, roX also has the ability to
direct binding of the MSL complex to autosomal chromatin in cis to roX transgenes
(KELLEY et al. 1999; KAGEYAMA et al. 2001). While the mechanisms that underlie the
ability to recruit the MSL complex in cis remain speculative, all studies to date suggest
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that recruitment is determined by the ratio of MSL protein to roX RNA (PARK et al. 2002;
OH et al. 2003; KELLEY et al. 2008). High levels of MSL protein are proposed to allow
formation of intact complexes as roX RNA is being transcribed, favoring localization
close to the site of transcription.

In contrast, when protein levels are low and roX

transcription is high, roX will be released from its site of synthesis before assembly of
the complex, eliminating the preference for local binding. Many questions remain about
the precise molecular mechanisms by which roX RNAs act, but it is clear that the roX
genes are central to X chromosome targeting.
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Figure 2.1. The roX transcripts localize to the X chromosome and are necessary
for X chromosome recognition. A) roX1 coats the X chromosome in a male salivary
gland. In situ hybridization to an antisense roX1 probe is detected by alkaline
phosphatase staining (purple). B) MSL1 localization in a polytene preparation from a
wild type male reveals exclusive localization to the X chromosome. Anti-MSL1 is
detected by Texas Red, DNA by DAPI. C) MSL1 localization in roX1 roX2 males is no
longer exclusive to the X chromosome (X), but appears at a number of ectopic
autosomal sites.
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Proteins of the MSL complex
The roX RNAs assemble with five proteins, collectively known as the Male
Specific Lethals (MSLs; reviewed by (MENDJAN and AKHTAR 2007; GELBART and KURODA
2009)). These are MSL1, -2, and -3 (Male Specific Lethal 1, -2, and -3), MLE
(Maleless), MOF (Males absent on the first). All of the MSL proteins are necessary for
dosage compensation. Mutation of any one of the msl genes causes male lethality as
third instar larvae or pupae. In spite of the male-limited role of the MSL complex, most
of the MSL proteins are present in both sexes, albeit at lower levels in females (LYMAN
et al. 1997; CHANG and KURODA 1998). MSL2 is the sole member of the complex whose
expression is limited to males (BASHAW and BAKER 1995; KELLEY et al. 1995; ZHOU et al.
1995). Translation of MSL2 mRNA is blocked by the Sexlethal protein, which is present
only in females (SXL; (CLINE and MEYER 1996; GEBAUER et al. 1998)).

Ectopic

expression of MSL2 in females leads to formation of intact MSL complexes that bind
both females X chromosomes, causing female lethality (KELLEY et al. 1995). Female
lethality is presumably due to elevated expression from both X chromosomes. This
supports the idea that maintenance of the correct ratio of X to autosomal gene products
is critical for normal development.
MSL2 and MSL1 are essential for all chromatin binding by the rest of the
complex (LYMAN et al. 1997; LI et al. 2005). MSL1 and MSL2 interact with each other,
and this protein-protein interaction has been postulated to form a joint DNA-binding
surface, although biochemical studies never confirmed this (RODRIGUEZ et al. 2007; LI et
al. 2008). Recent studies have identified the zinc-finger protein CLAMP as the DNAbinding factor (SORUCO et al. 2013). MSL1 also serves as a scaffold for assembly of the
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other MSL proteins, as carboxy-terminal regions of MSL1 interact with MOF and MSL3
(SCOTT et al. 2000; MORALES et al. 2004). MOF and MSL3 also interact with each other,
and both proteins have been reported to bind RNA (AKHTAR and BECKER 2000; SMITH et
al. 2000). MLE is the only member of the complex whose association with the other
MSL proteins appears to be indirect (COPPS et al. 1998). MLE is an RNA and DNA
helicase of the DExH subfamily (KURODA et al. 1991). MLE association with the polytene
X chromosome is RNA-dependent (RICHTER et al. 1996). MLE can be coimmunoprecipitated with roX2 RNA from SL2 cells (AKHTAR et al. 2000; SMITH et al.
2000). Two recent studies confirm MLE binding to roX1 and have identified sites of
interaction (ILIK et al. 2013; MAENNER et al. 2013). In early embryos prior to zygotic
MSL2 synthesis, roX1 stability depends on maternally deposited MLE (MELLER 2003).
Taken together, these observations suggest that MLE is tethered to the MSL complex
through roX RNA, and, in the absence of MLE, roX RNAs are not integrated into the
MSL complex, subjecting them to rapid degradation. MLE dependent remodeling of
roX1 is necessary for MSL2 binding, establishing an ordered assembly of the complex
(MAENNER et al. 2013). Localization of MOF and MSL3 has also been reported to be
sensitive to RNase treatment (AKHTAR et al. 2000; BUSCAINO et al. 2003). roX RNAs are
thus believed to play a major role in assembly of the MSL complex, and their continued
presence appears necessary for stable binding to the X chromosome.
While elimination of MSL1 or MSL2 results in loss of all chromatin binding by the
remaining member of the complex, elimination of MLE, MSL3 or MOF leaves residual
MSL proteins bound at a subset of X-linked sites.

These are proposed to be

recruitment sites from which the MSL complex can spread to nearby genes (KELLEY et

14

al. 1999). Indeed, recent studies have identified a short sequence motif enriched at
sites of strong MSL3-independent binding, termed MSL recognition elements (MRE;
(ALEKSEYENKO et al. 2008; STRAUB et al. 2008)). CLAMP is a DNA binding protein that
binds this sequence on the X chromosome and the autosomes (SORUCO et al. 2013).
Current models propose that the complete pattern of MSL binding along the X
chromosome involves attraction of the MSL complex to CLAMP at X-linked sites,
followed by spreading into transcribed genes situated nearby (GELBART and KURODA
2009). Examination of MSL binding at high resolution revealed enrichment in the body
and 3' ends of actively transcribed genes (LARSCHAN et al. 2007). This pattern is similar
to that of the cotranscriptional H3K36me3 mark, and this observation is explained by the
finding that the MSL3 chromodomain binds H3K36me3 (SURAL et al. 2008). Mutation of
conserved residues in the MSL3 chromodomain disrupts normal spreading of the MSL
complex into transcribed genes.

Taken together, these studies support an elegant

model that explains the local distribution of the MSL complex on the X chromosome.
What this model fails to explain is how the MSL complex is limited to the X
chromosome. All transcribed genes share enrichment for H3K36me3, and MREs are
only modestly enriched on the X chromosome. CLAMP also binds to many autosomal
MREs. If thus seems unlikely that these are the only factors directing localization of the
MSL complex.

A recent study determined that during interphase, regions of the X

chromosome with high affinity for the MSL complex are closer together than regions
with little or no binding (GRIMAUD and BECKER 2009). This suggests that interphase
chromosome architecture might be a factor in selective recognition of X chromatin.
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MOF is a histone acetyltransferase specific for lysine 16 on H4 (H4Ac16; (HILFIKER
et al. 1997; AKHTAR and BECKER 2000; SMITH et al. 2000)).

Histone acetylation in

general is thought to reduce the strength of histone-DNA interactions, making DNA
more accessible. The H4Ac16 modification specifically prevents tight packing of
nucleosomes, and this may contribute to elevated expression, as well as the slightly
decondensed character of the male X chromosome (SHOGREN-KNAAK et al. 2006). The
distribution of H4Ac16 enrichment is similar to that of the MSL complex, being more
pronounced in the 3' ends of genes and coding regions than on promoters of
transcribed genes (KIND et al. 2008). As chromatin modification by the MSL complex
occurs mainly within the body of genes, it is likely that enhanced transcription is due to
facilitation of elongation, rather than initiation of transcription (SMITH et al. 2001).
Modulation of a general property of RNA pol II, such as speed or processivity, would
explain how the MSL complex achieves a uniform two-fold increase in expression of
thousands of genes with disparate expression patterns and regulatory regions. Gene
run on studies demonstrate similar RNA polymerase II occupancy of the promoters of Xlinked genes, but higher enrichment in gene bodies, supporting this idea (LARSCHAN et
al. 2011).
A second chromatin modification is enriched on the male X chromosome and
depends on the MSL complex. The JIL-1 kinase is an essential protein required in both
sexes, yet partial loss of function alleles affect males more severely than females and a
genetic study suggests a role for JIL-1 in compensation of an X-linked gene (JIN et al.
1999). JIL-1 phosphorylates serine 10 on histone 3 (H3pS10), a mark that is associated
with open chromatin structure and increased gene expression (W ANG et al. 2001). JIL-1
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localizes to interband regions on all chromosomes and is enriched on the male X
chromosome. On the X, JIL-1 colocalizes with MSL proteins and, under some
conditions, it may immunoprecipitate with the MSL complex, suggesting a possible
molecular interaction (JIN et al. 2000; LERACH et al. 2005). However, it remains unclear
if JIL-1 enrichment on the X chromosome is due to a direct interaction with the MSL
complex or if it is the consequence of MSL complex action, for example, a response to
elevated transcription or chromatin modification by the MSL complex.
Separate domains of roX1 regulate X-localization and histone modification
At least one roX transcript is essential for targeting the intact MSL complex to the
male X chromosome (MELLER and RATTNER 2002; DENG and MELLER 2006). In roX1
roX2 males the proteins of the MSL complex still colocalize but are no longer exclusive
to the X chromosome. Although MOF is present at these ectopic autosomal sites in
roX1 roX2 males, H4Ac16 modification at these sites is low, suggesting that roX
association with the MSL complex is necessary for full MOF activity (DENG and MELLER
2006). Interestingly, the 3' end of roX1 contains a stem loop that is necessary for roX1
function, but deletion of this portion of the transcript has a relatively mild effect on Xlocalization (STUCKENHOLZ et al. 2003). In addition, short repeats in the 3' end of roX1
are also present in roX2, and in the roX genes of numerous related species (KELLEY et
al. 2008). The presence of these repeats appears to regulate activity of the complex
(PARK et al. 2007; KELLEY et al. 2008). While it is tempting to speculate that roX RNA is
the allosteric regulator of MOF, other MSL proteins also influence MOF activity.
Interaction of MOF with a subcomplex of MSL1 and MSL3 increases the efficiency and
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substrate specificity of MOF (MORALES et al. 2004). This emphasizes the point that the
normal activity of MOF requires assembly of the intact MSL complex.
In contrast to the function of 3' roX1 sequences, deletions removing significant
portions of the 5' end affect localization of the complex to the X chromosome
(STUCKENHOLZ et al. 2003; KONG 2012). This region comprises almost 1.5 kb and lacks
obvious repetitive sequences or secondary structures of high stability.

A scanning

deletion analysis that removed ~300 bp portions of roX1 failed to identify essential
elements in the 5' end (STUCKENHOLZ et al. 2003). However, deletions removing large
portions of this region reduce X chromosome binding of the MSL complex, although
mutants retaining even a very small portion of the 5' end support partial dosage
compensation (DENG et al. 2005; DENG and MELLER 2008). Together, these studies
support the idea that separate regions of roX1 direct MSL complex localization and the
chromatin modifying activity of the complex. This is reminiscent of the distribution of
function in Xist. Short, tandem stem loops are necessary for Xist-mediated chromatin
silencing in mice, but painting of the X chromosome is directed by several large
segments of Xist that may work cooperatively to ensure X recognition (W UTZ et al.
2002).
Ancestral origins of complexes that dosage compensate sex chromosomes
The sex chromosomes of mammals, C. elegans and flies are unrelated to each
other in evolutionary origin. Indeed, the de novo origin of differentiated sex
chromosomes has occurred repeatedly in different animal lineages (BULL 1985). In
accordance with this independent origin, sex chromosome dosage compensation has
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arisen independently many times. While each system for dosage compensation
achieves the goal of maintaining an appropriate ratio of X to autosomal gene products,
each has adopted a completely different strategy to do so. All three systems have
developed through recruitment of preexisting chromatin regulatory complexes (Table
2.1).
Table 2.1. Dosage compensation
complexes for novel functions.

Organism
C. elegans

Mammals

Compensation
Machinery
DCC complex

PRC2

Drosophila MSL complex

recruits

existing

chromatin-modifying

Compensatory
Function
Down regulation of

Ancestral Complex and
Function
Condensin mitotic and meiotic

X-linked genes

chromosome condensation1.

inactivation of X

PRC2 developmentally stable

chromosome

repression2.

Up regulation of X-

Complexes with broad roles

linked genes

in gene regulation and DNA
repair (See Table 4.1)

1

(CHAN et al. 2004; CSANKOVSZKI et al. 2009),
al. 2013),

2

(SCHOEFTNER et al. 2006; FROBERG et

For example, the dosage compensation complex (DCC) of C. elegans is related
to, and shares subunits with, the condensin complex that compacts chromosomes and
enables normal segregation during mitosis and meiosis (CHAN et al. 2004; CSANKOVSZKI
et al. 2009). In accordance with this, some mutations that disrupt C. elegans dosage
compensation also disrupt meiosis and mitosis (HAGSTROM et al. 2002). Silencing of an
X chromosome in female mice is a complex process that takes place over several days
during early embryogenesis, but an early event is recruitment of the Polycomb
repressive complex 2 and 1 (PRC2 and PRC1) complexes (SCHOEFTNER et al. 2006;
ZHAO et al. 2008). PRC2 deposits the silencing H3K27 tri-methylation mark and Pcg1
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ubiquitinates H2 on K119 (PLATH et al. 2003; KOHLMAIER et al. 2004).

These

modifications may contribute to the stability of X inactivation (FROBERG et al. 2013). In
addition to their role in X inactivation, both complexes continue to function in epigenetic
repression throughout the genome during mammalian development (BERNSTEIN et al.
2007).
While the ancestral functions of the proteins that achieve dosage compensation
in Drosophila remain to be fully defined, homologues of MOF, MSL1, MSL2 and MSL3
have been found in organisms as diverse as yeast and mammals (MARIN and BAKER
2000; EISEN et al. 2001; SANJUAN and MARIN 2001; MARIN 2003). With the exception of
MLE, the mammalian homologues associate with each other, suggesting that the
modern MSL complex of flies has an ancient origin. Human MOF (hMof) is notable as it
participates in multiple complexes, and these are responsible for the majority of
H4KAc16 modification in mammalian cells (SMITH et al. 2005; MENDJAN et al. 2006; CAI
et al. 2010). Although the precise molecular function of hMOF containing complexes is
not clear, depletion of hMof affects DNA repair, possibly by disruption of damage
signaling (GUPTA et al. 2005; TAIPALE et al. 2005; REA et al. 2007).

MOF also

participates in multiple complexes in flies, which may allow it to serve as a general
regulator of chromatin at promoters although this finding remains controversial (KIND et
al. 2008; GELBART et al. 2009; CONRAD et al. 2012b; FERRARI et al. 2013; STRAUB and
BECKER 2013; VAQUERIZAS et al. 2013).

Recent work in our laboratory suggests a

different autosomal role for MOF, and other MSL proteins, in flies.
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Regulation of heterochromatic genes by roX and a subset of MSL proteins
In addition to reduced expression of X-linked genes in roX1 roX2 males, several
hundred autosomal genes situated in heterochromatic regions are also misregulated
(DENG et al. 2009).

Regions containing misregulated genes include the entire 4th

chromosome. The 4th chromosome has several peculiarities, including its small size,
lack of recombination and possible evolutionary kinship with the X chromosome
(LARSSON and MELLER 2006; RIDDLE and ELGIN 2006). However, the fact that the 4th
chromosome is enriched for heterochromatin is the feature that it shares with the other
autosomal genes that depend on roX RNA for full expression.

Unexpectedly, this

feature of heterochromatic gene regulation is limited to males (Chapter 3; (DENG et al.
2009)). Analysis of expression in msl mutants revealed that MSL1, MSL3, MLE and
MOF are also required for full expression of heterochromatic and 4th-linked genes in
males (Chapter 3, 4). However, no misregulation of these autosomal genes is observed
in msl2 mutants, indicating that the intact MSL complex is not involved (Chapter 3;
(DENG et al. 2009)). Because MSL2 is the sole member of the MSL complex that is
strictly male-limited, it remains unclear how the sex-specificity of heterochromatic gene
regulation is maintained. As MSL1 and MSL2 are postulated to work together to target
the MSL complex to the X chromosome, it appears likely that MSL2 is dedicated to
recognition of the X chromosome (RODRIGUEZ et al. 2007; LI et al. 2008). The X
chromosome is about two-fold enriched for MREs in comparison to the autosomes, but
interestingly, MREs are depleted from the 4th chromosome (ALEKSEYENKO et al. 2008).
This reinforces the idea that although regulation of X-linked and heterochromatic genes
requires overlapping sets of molecules, recognition of these two groups occurs by
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different mechanisms. To explain these findings, we have proposed that a second
complex composed of roX RNA and subset of MSL proteins is responsible for
modulation of chromatin at autosomal heterochromatic sites in males.
It is tempting to speculate that regulation of heterochromatic genes reflects an
ancestral function of the members of the MSL complex. Heterochromatic genes are
situated in a difficult environment, and have long been thought to utilize specialized
regulatory mechanisms (YASUHARA and W AKIMOTO 2006). However, the limitation to
males suggests a process that coevolved with the modern sex chromosomes of flies.
One possibility is that the highly differentiated sex chromosomes create nuclear
environments that are sufficiently different to require a dedicated regulatory system in
one sex. As the Drosophila Y chromosome is large and entirely heterochromatic, it is
plausible that it alters the balance of chromatin proteins throughout the nucleus (W EILER
and W AKIMOTO 1995). Taking into account the multiple functions of roX RNA in genome
regulation, we present a hypothetical model for the origin of roX-dependent complexes
in Figure 2.2. In human cells, homologues of MLE and roX have not been identified in
association with the other hMSL proteins (GUPTA et al. 2005; SMITH et al. 2005; TAIPALE
et al. 2005; CAI et al. 2010). Because of this we have chosen to model the acquisition
of roX and MLE as an early step in evolution of modern roX-containing complexes of
flies. Rapid co-evolution of the MSL2 and MSL1 interaction domains has been linked to
the recruitment of this complex to dosage compensation (fig. 2.2 left). MSL2 is the sole
member of this complex lacking a heterochromatic role, and is thus anticipated to be
dedicated to X recognition.

We speculate that loss or replacement of MSL2 has

enabled the remaining MSL proteins and roX RNA to be recruited for a different

22

purpose, regulation of heterochromatic genes in males. While it appears logical that a
subset of MSL proteins and the roX RNAs form a second complex, the existence of this
has yet to be demonstrated. Although studies in flies have identified multiple MOFcontaining complexes, the technique used, affinity purification followed by mass
spectrometric analysis, would not reveal a minor contribution of a subcomplex lacking
MSL2 (MENDJAN et al. 2006; CAI et al. 2010). The mechanism by which autosomal
genes are regulated by the roX RNAs remains to be fully elucidated.
Conclusions
The large non-coding roX RNAs have a central role in sex chromosome dosage
compensation in flies, where they fulfill a role with similarities to that of Xist during
mammalian dosage compensation. roX transcripts assemble with the MSL proteins to
form a complex that displays exclusive X chromosome binding. Situation of the roX
genes on the X chromosome facilitates X recognition through the ability of the roX
genes to attract the MSL complex in cis. These observations created the impression
that the roX RNAs were dedicated to identification and modification of the X
chromosome, but this idea has been revised by the unexpected discovery of a role for
roX in expression of heterochromatic genes. It appears that both regulatory systems
may be necessitated by the presence of highly differentiated sex chromosomes.
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Figure 2.2. Proposed origin of roX RNA complexes in Drosophila. As homologues
of MSL1, MSL2, MSL3 and MOF associate in many organisms, this association may
represent the ancestral form of the complex in flies (top). We speculate that acquisition
of MLE and roX was an early event in formation of the modern MSL complex, followed
by co-evolution of MSL1 and MSL2 (left), a feature that may determine X recognition.
Loss or replacement of MSL2 may enable complex members to acquire autosomal
functions such as regulation of genes in heterochromatic environments (right). While the
association of roX and MSL proteins in the intact MSL complex (left) is well established,
the presence of a subcomplex lacking MSL2 (right) has yet to be established.
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Chapter 3
AN AUTOSOMAL FUNCTION FOR MSL COMPLEX MEMBERS
The work described in this chapter has been published as part of ‘Deng X*.,
Koya S.K.*, Kong Y., and Meller V.H. (2009) Coordinated regulation of
heterochromatic genes in Drosophila melanogaster males. Genetics. 182(2): 481491.’
*co-first authors
Introduction:
Complex eukaryotic genomes require complex regulation. Gene regulation is
usually though to occur locally, at single genes, by cis-acting DNA sequences and
trans-acting proteins. But in some cases gene regulation is a global event. Dosage
compensation is an example of global regulation. Global gene regulation involves
changes in chromatin architecture and biochemistry of a group of genes that are to be
regulated.
Many diploid species, such as round worms, dipterans and mammals, determine
sex with sex chromosomes. Females and hermaphrodites have two X chromosomes
but males have single X chromosome (XY or XO). This creates an imbalance in Xlinked gene dosage between males and females. Different species have developed
different strategies to balance X-linked gene expression between males and females, a
process called dosage compensation. Drosophila melanogaster males increase
expression from their single X chromosome two fold in order to equal expression of the
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two X chromosomes of females. This is accomplished by a complex of proteins and
RNAs called Male Specific Lethal (MSL) complex (LARSSON and MELLER 2006).
The MSL complex contains five proteins and two noncoding RNAs. Mutation of
any of the MSL proteins causes male lethality as third instar larvae or pupae (LARSSON
and MELLER 2006). The roX1 and roX2 RNA are essential and integral components of
MSL complex (MELLER and RATTNER 2002). The roX RNAs are also necessary to target
the MSL complex to the X chromosome. Mutation of either roX gene alone is not lethal,
due to the functional redundancy of these RNAs. Simultaneous mutation of roX1 and
roX2 causes male-specific lethality, emphasizing the functional importance of these
RNAs for dosage compensation.
In previous studies, roX1 roX2 double mutants showed chromosome-wide
reduction of X chromosome expression, as expected (DENG and MELLER 2006). But
surprisingly, expression of the entire 4th chromosome was also reduced (DENG et al.
2009). This effect on the 4th chromosome might be due to trivial causes, or be indirect
effects of the roX1 roX2 mutations. For example, mislocalization of MSL proteins to
pericentromeric regions might cause non-disjunction and loss of the 4th chromosome in
roX1 roX2 males. However, mitotic neuroblast preparations from larval brains of roX1
roX2 males revealed no 4th chromosome loss (DENG et al. 2009). Alternatively, ectopic
binding of MSLs to the 4th chromosome might cause repression in roX1 roX2 males.
Recapitulation of ectopic binding of MSL proteins to the 4th chromosome in roX1 roX2
females by forced expression of MSL2 failed to disrupt expression of 4th chromosome
genes (DENG et al. 2009). It is therefore possible that the roX RNAs serve a specific role
in regulation of the 4th chromosome.

26

To address the mechanism of misregulation of the 4th chromosome in roX1 roX2
mutant males, I explored the possibility that the heterochromatic nature of the 4th
chromosome makes it sensitive to loss of roX RNA. I reanalyzed gene expression
microarrays done with roX1 roX2 males and discovered that genes embedded in
heterochromatin on the 2nd and 3rd chromosomes also have reduced expression. I then
evaluated additional members of the MSL complex in this process by using microarrays
or qRT PCR to examine gene expression in male larvae mutated for msl1, msl2 and
msl3. These studies revealed that MSL1 and MSL3 are necessary for full expression of
heterochromatic genes, but MSL2 is not.

This demonstrates that the intact MSL

complex does not regulate heterochromatic regions. It also eliminates the possibility
that loss of dosage compensation causes misregulation of heterochromatic genes
through an indirect mechanism, as MSL2 is critical for compensation but unnecessary
for full expression of autosomal heterochromatic genes.
MATERIALS AND METHODS
Drosophila strains
Flies were maintained at 25° on standard cornmeal-a gar fly, food in a humidified
incubator. The roX1ex6 and roX1mb710 mutations have been described (MELLER et al.
1997; DENG et al. 2005). Elimination of roX2 is accomplished by combining a lethal
deletion removing roX2 and essential flanking genes, Df(1)52, with a cosmid insertion
carrying essential deleted genes but lacking roX2 ([w+4∆4.3] (MELLER and RATTNER
2002)). For convenience this combination is referred to as roX2. The msl11 mutation
has been previously described (BELOTE and LUCCHESI 1980). msl21 is EMS induced
mutation that has been previously described (ZHOU et al. 1995). msl32 is a EMS induced
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mutation (LINDSLEY 1992). Males mutated for msl1 and msl2 generally are not healthy
enough to be selected by gonad morphology. To select msl11 males, yw; msl11 females
were mated to y+w; msl11/CyOy+ males. Only msl11 males are y+ and have brown
mouth hooks. To select msl21 males, yw; msl21 females were mated to y+w[w+PD27];
msl21 males. The [w+PD27] insertion carries msl2 and rescues msl21 males (KELLEY et
al. 1995). All male offspring from this cross are yw; msl21, and all female offspring are
y+.
Quantitative RT-PCR
Total RNA was made from 3 groups of at least 50 larvae of each genotype. One
µg of total RNA was reverse transcribed using random hexamers and ImProm-II reverse
transcriptase (Promega). Quantitative PCR was performed as previously described
(DENG et al. 2005). A total of 34 genes were selected from four different gene groups (2
and 3 euchromatic, 2 and 3 heterochromatic, 4th chromosomal and X-chromosomal).
The selected genes were expressed at moderate levels, displayed uniform absorbance
in arrays of the same genotype and reflected the average change in expression for their
gene group in roX1 roX2 males. An exception is the X-linked Lsp-1α gene, which is
known to escape dosage compensation. Bigmax and Dmn are autosomal genes that
proved reliable for normalization of expression (data not shown). The primers used in
this study are presented in APPENDIX B.
Gene expression microarrays
Total RNA was prepared from groups of at least 50 third instar larvae using the
TRIzol method (Invitrogen) and purified using the RNeasy kit (Qiagen). Three
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independent RNA preparations for each genotype served as templates for probe
synthesis (see protocol at www.Affymetrix.com). Probes were hybridized to Affymetrix
Drosophila Genome 2.0 chips (Santa Clara, CA).

Background corrected intensity

values were quantile normalized (IRIZARRY et al. 2003). In brief, all probe intensities
from mutant and control arrays were assembled into a single ranking. Probes from
individual chips were assigned the value of the corresponding quantile, thus preserving
the rank order within a chip and standardizing intensity distribution across all chips.
Intensities were summarized into one expression value per sample and probeset using
the

RMA

(Robust

Multi-array

Average)

algorithm.

The

Affymetrix

MAS5.0

Present/Absent calls were used to filter out probesets not present in at least 2 out of 3
replicates of each genotype.
Genes and probe sets (Berkeley Drosophila Genome Project annotation release
5.8) were sorted to enrich for heterochromatic genes based on the boundaries between
heterochromatic and euchromatic regions (HOSKINS et al. 2007; SMITH et al. 2007). The
co-ordinates of these boundaries are: 2R;1-1285689, 2L;220,0097,52,3011,544, 3R;1378,656, 3L;2,2955,576-2,4543,557, X;2,2030,326-2,2422,827. The coordinates for
heterochromatin that is not contiguous with assembled arm sequences are 2LHet;1368,872, 2RHet;1-3288,761, 3LHet;1-2555,491, 3RHet;1-2517,507, XHet;1-204,112,
YHet; 1-347,038. Only probe sets assigned to a chromosome were used. Genes and
probe sets assigned to heterochromatic regions were obtained from Flybase GBrowse.
The corresponding gene and probe set information was obtained from the Affymetrix
Drosophila_2 annotation file (Drosophila_2.na25) released on March 17th 2008 (LIU et
al. 2007).
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Statistical methods and descriptions
The log2 fold change of each gene was computed as the log2 mean RMA
expression of mutant samples minus the log2 mean RMA expression of control samples.
The significance of differences between groups was assessed by the Wilcoxon test.
Analyses were performed in the R software environment (www.r-project.org) using
Bioconductor (www.bioconductor.org; (GAUTIER et al. 2004; SMYTH 2005)). The raw data
can

be

downloaded

from

the

Gene

Expression

Omnibus

(http://www.ncbi.nlm.nih.gov/geo, GSE3990; GSE12054; GSE12076).
qRT-PCR data was analyzed by the efficiency corrected comparative
quantification method (PFAFFL 2001). Ct values for three biological replicates (each
containing two technical replicates) per genotype were averaged into one Ct value per
gene. The relative quantities (mutant : control) were tested for normality using the
Shapiro-Wilk test. As the MSL1 and MSL3 data sets were not normally distributed, the
nonparametric Mann-Whitney U test was used to determine significance. Descriptive
statistics are in APPENDIX A.
Results
roX RNA is necessary for normal expression of autosomal heterochromatic genes
The

4th

chromosome

is

highly

heterochromatic.

Genes

embedded

in

heterochromatin are presumed to have specialized regulatory features that enable
expression in spite of their repressive heterochromatic environment (YASUHARA and
WAKIMOTO 2008). A possible reason for reduced expression of the 4th chromosome in
roX1 roX2 males might be a requirement for roX RNA for full expression of
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heterochromatic genes. If the proximity of 4th-linked genes to heterochromatin makes
them dependent upon roX RNA, expression of genes in pericentric heterochromatin on
the 2nd and 3rd chromosomes should also depend on roX RNA. To address this
question, data sets from microarrays of roX1 roX2 (mutant) and roX2 (control) male
larvae were reanalyzed to determine the expression of heterochromatic genes on other
linkage groups (DENG and MELLER 2006). Heterochromatic genes on chromosome 2
and 3 were identified based on a published estimation of the boundaries between
euchromatin and heterochromatin (HOSKINS et al. 2007). Expression of heterochromatic
genes on the 2nd and 3rd chromosomes decreased by 17 % in roX1 roX2 males, but
remained unchanged in roX1 roX2 females (Fig. 3.1). This suggests that proximity to
heterochromatin could account for the dependence of 4th-linked genes on roX RNA.
Down regulation of heterochromatic gene expression is not an indirect effect of
failure of dosage compensation
Reduced expression of 4th chromosomal and heterochromatic genes might be
due to an indirect effect of the failure of dosage compensation. In roX1 roX2 males,
there is reduced expression of the X chromosome. It is possible that normal expression
of a gene or group of genes on the X is necessary for normal expression of the 4th
chromosome. If this is the case, there should be reduced 4th chromosome expression in
all msl mutants. Alternatively, members of the MSL complex might have a second role
in regulation of 4th chromosome and heterochromatic genes. If this is the case, it is
possible that some msl mutations will affect one process but not the other. MSL2 is the
only protein that is strictly limited to males. Expression of MSL2 is inhibited in females
by the female-limited Sexlethal (SXL) protein. MSL2, together with MSL1, forms the
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core of the MSL complex. I examined heterochromatic gene regulation in msl2 mutant
males.

These males rarely survive to the third instar larval stage. Two studies

demonstrated reduced expression of the X chromosome in male S2 cells following msl2
RNAi knock down (HAMADA et al. 2005; STRAUB et al. 2005), and examination of data
from one of these studies detected no change in 4th-linked or heterochromatic genes
(HAMADA et al. 2005; DENG et al. 2009). While this is suggestive, it is possible that RNAi
knock down is incomplete, or that MSL2 acts transiently to establish a male-specific
configuration in heterochromatic regions. To address these concerns, microarrays were
hybridized to probes from msl21 male larvae and msl21/+ controls.

MSL2 is not

maternally deposited, therefore msl21 larvae lack this protein entirely (RASTELLI et al.
1995). Expression from the X chromosome was reduced by 21% in male msl21 larvae
(Bonferroni corrected p-value <2.2X10-16; Fig. 3.2A). While this is less than the 50%
reduction expected for dosage compensation failure, it compares well with the 22%
decrease upon MSL2 knock down in S2 cells (HAMADA et al. 2005).

By contrast,

expression of heterochromatic and 4th-linked genes appears unchanged, or slightly
increased, in msl21 males (0.07 and 0.11 fold, respectively). We conclude that the
intact MSL complex is not necessary for full expression of 4th-linked and
heterochromatic genes.
MSL1 and MSL3 are required for normal expression of X-linked and autosomal
heterochromatic genes.
MSL1 and MSL2 interact directly, and MSL1 protein acts as a scaffold for
assembly of other MSL proteins in the MSL complex (COPPS et al. 1998; SCOTT et al.
2000). MSL1, along with MSL2, is necessary for all X chromosome binding by the MSL
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complex (SCOTT et al. 2000; LI et al. 2005). To determine the role MSL1, I examined
the

expression

of

a

panel

of

X-linked,

autosomal

euchromatic,

autosomal

heterochromatic and 4th-linked genes in msl11 and msl11/+ male larvae. Expression of
4th-linked genes decreased by 38% in comparison with euchromatic genes on the 2nd
and 3rd chromosomes, and heterochromatic genes on the 2nd and 3rd chromosomes
were reduced by 33% (Fig. 3.2B). These changes are significant at the 0.003 and
0.002 level when evaluated using a two-tailed Mann-Whitney U Test (APPENDIX A).
MSL3 is MRG family protein with reported RNA binding activity (MORALES et al.
2005). It binds to MSL1 directly and it is acetylated by MOF (BUSCAINO et al. 2003;
MORALES et al. 2004). MSL3 helps target MSL complex to the body of active genes by
binding the histone 3 lysine 36 tri-methylation mark (H3K36me3; (LARSCHAN et al.
2007)). As MSL3 plays an important role in regulation of the X chromosome, I wanted
to investigate its role in heterochromatic gene regulation. I compared expression of Xlinked, autosomal euchromatic, autosomal heterochromatic and 4th–linked genes in
homozygous msl32 male larvae and their heterozygous brothers using qRT-PCR (Fig.
3.2C).

Expression from 4th-linked genes decreased by 24%, and expression from

heterochromatic genes decreased by 36% in msl32 males in comparison to autosomal
euchromatic expression. These decreases are statistically significant at the 0.032 and
0.036 level (see APPENDIX A). Taken together, these findings indicate that some, but
not all, of the MSL proteins are necessary for full expression of 4th-linked and
heterochromatic genes in male flies.
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Figure 3.1: Genes situated in heterochromatin require roX RNA for full expression
in males.
(A) Genes in heterochromatin have reduced expression in roX1SMC17A roX2 male
larvae. The mean expression of genes in proximal heterochromatin on the second and
third chromosomes decreases by 0.17 in roX1SMC17A roX2 males (adjusted P-value of
0.003). The mean expression of X-linked genes decreases by 0.24, and expression of
fourth-linked genes decreases by 0.58. Changes of the X and fourth chromosome have
an adjusted P-value of <6.63 X 10-16. Only genes present in at least 2 out of 3 arrays
contributed to this analysis (8347 in second and third euchromatin; 1533 in X
euchromatin, 73 in second and third heterochromatin, and 74 on the fourth
chromosome). Box plots were generated using the log2 expression ratios
(mutant/control).

(B) Fourth-linked and heterochromatic genes do not require roX RNA for full
expression in females. Box plots were generated using the log2 expression ratios
(mutant/control). The mean change in expression of X-linked genes in roX1SMC17A roX2
females is -0.04. Second and third chromosome heterochromatic genes and fourth
linked genes have a slight average increase (0.06 and 0.01, respectively) that is not
expected to be biologically significant. Only genes present in at least 2 out of 3 arrays
contributed to this analysis (7097 in second and third euchromatin, 1336 in X
euchromatin, 57 in second and third heterochromatin, and 69 on the fourth
chromosome).
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Figure 3.2: MSL1 and MSL3, but not MSL2, are required for full expression of
heterochromatic autosomal genes.
(A) Fourth-linked and heterochromatic genes are normally expressed in msl21
male larvae. Box plots represent the log2 (mutant:control) expression of the indicated
groups of genes. Expression was measured by hybridizing microarrays to probes
generated from msl21 and msl21/+ (control) male larvae. Heterochromatic gene sorting
is described in materials and methods.

(B) Fourth-linked and heterochromatic genes require MSL1 for full expression.
Expression of a panel of genes was measured in msl11 males and their heterozygous
brothers (controls). Seven euchromatic genes on the 2nd and 3rd chromosomes; 4
euchromatic X-linked genes, 12 4th-linked genes, and 10 heterochromatic genes on the
2nd and 3rd chromosomes were measured (see APPENDIX B). Expression of
heterochromatic and fourth-linked genes differs from euchromatic 2nd and 3rd
chromosome genes at the 0.003 and 0.002 confidence level, respectively.

(C) Fourth linked and heterochromatic genes require MSL3 for full expression.
Expression of a panel of genes was measured in msl32 males and their heterozygous
brothers (controls). Four euchromatic X-linked genes, 7 euchromatic genes on the 2nd
and 3rd chromosomes; 13 4th-linked genes, and 10 heterochromatic genes on the 2nd
and 3rd chromosomes were measured. Expression of heterochromatic and 4th-linked
genes differs significantly from euchromatic autosomal gene expression at the 0.032
and 0.036 confidence levels. Dmn was used to normalize amplification. Box plots were
generated using Bioconductor R. See materials and methods for details of statistical
analyses.
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DISCUSSION
roX RNA participates in two distinct biological processes; X chromosome dosage
compensation and normal heterochromatin function in males. Involvement of roX RNA
in heterochromatic function is striking and unexpected. Our findings indicate that down
regulation of autosomal heterochromatic genes in roX and msl mutants is not an indirect
affect of dosage compensation failure. Our findings also reveal that the intact MSL
complex is not required for heterochromatic gene regulation. This suggests that roX
RNA and a subset of the MSL proteins have an autosomal function in males. In light of
this, a short sequence motif, the MSL recognition element (MRE), found in chromatin
entry sites on the X chromosome, is depleted from 4th chromosome, in comparison the
other autosomes (ALEKSEYENKO et al. 2008). This suggests selective pressure to
prevent inappropriate binding of the MSL complex to the 4th chromosome, and supports
our conclusion that the intact MSL complex does not associate with or regulate this
chromosome

Limitation of the roX requirement for heterochromatic gene expression to males
is puzzling. In light of this, mutations in heterochromatin proteins present sex-biased
phenotypes. Enrichment of Heterochromatin Protein 1 (HP1) is somewhat different in
males and females, and conditional depletion of HP1 causes preferential lethality in
males (LIU et al. 2005a). Our findings further suggest that sex-specific differences exist
in heterochromatin. Several additional studies suggest links between dosage
compensation and heterochromatin. HP1 is modestly enriched on the male X
chromosome and mutation of HP1 or Su(var)3-7, an HP1 binding partner, disrupts the
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structure of the polytenized male X chromosome (DE W IT et al. 2005; SPIERER et al.
2005; SPIERER et al. 2008). The JIL-1 kinase is genetically linked to dosage
compensation and enriched on the male X chromosome (LERACH et al. 2006). JIL-1
mutations suppress position effect variegation (PEV) in pericentromeric regions and
permit proximal heterochromatin to spread into euchromatic chromatin (EBERT et al.
2004; LERACH et al. 2006; ZHANG et al. 2006). While JIL-1 is a plausible link between
dosage compensation and heterochromatin, the effect of JIL-1 mutations on
heterochromatin and PEV is observed in both sexes.

It is tempting to speculate that roX RNA, MSL1 and MSL3 associate, as they do
in the MSL complex.

Although efforts to detect roX1 and MSL proteins on the 4th

chromosome of polytene preparations have not been successful, it is possible that
these molecules have a transient role in heterochromatic regions. While members of the
MSL complex are interdependent in larvae, in early embryos maternally deposited
MSL1 and MSL3 are present and stable prior to the zygotic expression of MSL2 at 3 h
AEL. Similarly, roX transcripts are unstable in larvae lacking any MSL protein, but roX1
produced in early embryos is stable for several hours, even in the absence of MSL2
(MELLER et al. 1997; MELLER 2003).

roX1 is first transcribed over an hour before

dosage compensation is initiated, but just before heterochromatin becomes visible
(VLASSOVA et al. 1991; LU et al. 1998). MSL1, MSL3 and roX1 are therefore present
during the initial formation of heterochromatin, making it plausible that they serve a
transient role at this time. Expression of MSL2 in males at 3 h triggers formation of the
intact MSL complex.

Sequestration of MSL proteins and roX1 RNA to the X
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chromosome is believed to then occur. The window between 1.2 and 3 h may thus be a
critical time during which roX influences heterochromatin structure. This idea is
investigated and discussed in chapter 4.
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Chapter 4
A subset of MSL proteins localizes to autosomal sites and modulates
heterochromatin in Drosophila melanogaster males.
This chapter is a manuscript in preparation (Koya, S. K. and Meller,
V. H., in preparation)
Abstract
In Drosophila melanogaster males, the ribonucleoprotein Male Specific Lethal
(MSL) complex is required for X chromosome dosage compensation. Initiating at 3 h of
embryonic development, this complex binds active X-linked genes and modifies
chromatin to facilitate transcription. We recently demonstrated that several members of
the MSL complex are also required for full expression of heterochromatic genes in
males, but not females. Loss of the non-coding roX RNAs, essential components of the
complex, lowers the expression of heterochromatic genes and suppresses position
effect variegation (PEV) in males, revealing a sex-limited disruption of heterochromatin.
To explore the molecular basis of this observation, we examined the role of the
remaining MSL proteins and found that MOF and MLE, but not Jil-1 kinase, contribute to
heterochromatic gene expression. To determine if identical regions of roX1 are required
for dosage compensation and heterochromatic silencing, we examined both processes
with a panel of roX1 deletions, and find that roX1 functions are partially separable by
some mutations.

Chromatin immunoprecipitation of staged embryos revealed that

MSL3 binds to autosomal genes, and to genes in heterochromatic regions, prior to the
onset of dosage compensation, suggesting a direct role at these sites. These findings
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support the idea that MSL complex members participate in additional complexes that
target distinct sets of genes.
Introduction
Heterochromatin makes up one third of the Drosophila melanogaster genome.
Half of the X chromosome, most of the 4th chromosome and the entire Y chromosome
are heterochromatic. Heterochromatin is primarily composed of repetitive, non-coding
DNA, but hundreds of genes are also embedded in these regions. The structure of
heterochromatin is generally thought to be independent of sex, but some differences in
male and female heterochromatin have been detected. Conditional depletion of
heterochromatic protein 1 (HP1), a major component of heterochromatin, caused
preferential lethality and misregulation of genes in males (LIU et al. 2005b). These
authors also found that distribution of HP1 is slightly different in males and females. In
accord with these observations, our laboratory discovered that full expression of
autosomal heterochromatic genes in males requires a set of factors that is unnecessary
in females (DENG et al. 2009). In brief, a subset of molecules in the Male Specific Lethal
(MSL) complex, including roX RNA, MSL1 and MSL3, is necessary for full expression of
heterochromatic genes. Furthermore, Position Effect Variegation (PEV) of insertions in
autosomal heterochromatin is suppressed in roX mutant males, but not in females
(DENG et al. 2008). Taken together, these findings suggest that a subset of molecules
in the MSL complex is necessary for normal function of male, but not female,
heterochromatin.

41

In this study we examine roX1 mutants to determine whether the dosage
compensation and heterochromatin functions of roX1 are separable.

We find that

maintenance of PEV is achieved at much lower levels of roX1 RNA than are required for
dosage compensation, and requires regions of roX1 that are non-essential for dosage
compensation. We extend previous studies by demonstrating a role for MLE and MOF,
but not Jil-1, in heterochromatic gene expression in males. To explore the possibility
that a subset of MSL proteins interacts directly with autosomal targets, we examined
MSL3 localization during early embryogenesis and discovered that this protein has
broad autosomal binding prior to dosage compensation. Autosomal binding is lost in
embryos lacking MSL1, revealing interdependency.

Taken together, these findings

suggest that roX RNA and a subset of the MSL proteins participate in a separate
complex that is binds to chromatin throughout the genome during early development.
Results:
Analysis of heterochromatic gene expression in MSL mutants.
Previous studies revealed that MSL1, MSL3 and roX RNA, but not MSL2, are
necessary for full expression of heterochromatic genes (DENG and MELLER 2009). This
eliminates the possibility that the intact MSL complex is involved in this process. To
determine the heterochromatic role of remaining members of the complex, we
measured the expression of panels of autosomal euchromatic and heterochromatic
genes in mutant male larvae.
MOF is a histone acetyltransferase (HAT) that modifies lysine 16 on H4
(H4K16Ac), a mark enriched in compensated genes (HILFIKER et al. 1997; SMITH et al.
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2001; KIND et al. 2008). Protein lacking HAT activity is present in mof1 flies, but no MOF
protein is found in mof2 mutants (HILFIKER et al. 1997; GU et al. 1998). Both alleles are
male lethal. While mof1 females are healthy and fertile, mof2 females are only weakly
fertile, suggesting that MOF fulfills additional, non-catalytic functions (GELBART et al.
2009). We used quantitative RT-PCR (qRT PCR; Fig. 4.1 A, B) to determine gene
expression in mof1 and mof2 male larvae. Expression was normalized to Dynamitin
(Dmn) and yantara (ytr), two euchromatic autosomal genes previously shown to have
consistent expression (DENG et al. 2009).

As expected, X-linked genes display a

reduction in expression in both mof mutants. Genes on the largely heterochromatic 4th
chromosome are also reduced, but heterochromatic genes on the 2nd and 3rd
chromosomes remain do not display statistically significant change in mof1 mutants.
MLE is necessary for normal expression of heterochromatic genes.
As MLE binds roX RNA and participates in assembly of the MSL complex, it is a
likely cofactor in other roX-dependent processes (AKHTAR et al. 2000; ILIK et al. 2013;
MAENNER et al. 2013). Expression of heterochromatic genes was examined in mle1
male larvae (Fig. 4.1, C). In addition to X-linked genes, heterochromatic genes on the
2nd, 3rd and 4th chromosomes displayed significant reductions in expression in mle1
males, suggesting that MLE is required for heterochromatic gene regulation.
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Figure 4.1. MOF and MLE, but not JIL-1,
play a role in expression of autosomal
heterochromatic genes. Expression was
measured in (A) mof1, (B) mof2, (C) mle1, (D)
Jil-1z2 mutant males and heterozygous
(mle/+; Jil-1/+) or complemented (mof; [mof+]
control males using qRT-PCR (see materials
and methods for details). Gene groups are,
from left to right, euchromatic autosomal
(chromosome 2 and 3) or X-linked,
heterochromatic autosomal (chromosome 2
and 3) and 4th-linked. The Log2 expression
(mutant/control) is plotted on the y-axis. The
number of genes tested per group are, left to
right, 6 (8 for mle1), 4, 10 and 14. Box plots
were generated using R. p-values were
determined by a Wilcoxon test. Significant
comparisons are indicated with an asterisk.
mof1 p-values for 4th-linked = 0.0009; mof2 pvalues for heterochromatic autosomal = 0.019
and 4th-linked = 0.001953; mle1 p-values for
heterochromatic autosomal = 0.003 and 4th linked = 0.001. The X-linked genes, included
as a positive control, represented too small a
sample to generate a reliable p-value.
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Analysis of gene expression in Jil-1 mutants.
The kinase Jil-1 contributes to general chromatin organization and is essential in
both sexes. However, hypomorphic Jil-1 mutations affect males more strongly than
females, and, while Jil-1 binds interband regions throughout the genome, it is enriched
on the male X chromosome (JIN et al. 1999; JIN et al. 2000; W ANG et al. 2001; LERACH
et al. 2005; REGNARD et al. 2011). We measured gene expression in Jil-1z2 animals,
and found that none of the groups of genes examined displayed a change in
expression, suggesting that Jil-1 does not participate in regulation of heterochromatic
genes (Fig. 4.1 D).
To determine the critical time for roX and MSL regulation of heterochromatin, we
developed a genetic assay that takes advantage of PEV as an indicator of
heterochromatic silencing. A heat shock inducible roX1 transgene system was used to
control roX1 expression (KELLEY et al. 2008). Flies were constructed with the partial
loss of function yw roX1ex33 roX2∆ X chromosome, which supports 20% male escapers
that display dramatic suppression of PEV (DENG et al. 2005). A variegating y+ reporter
inserted in second chromosome heterochromatin (p[SUP or-P] KV0020; hereafter KV20
(KONEV et al. 2003)), and a 3rd chromosome roX1 expression system ([w+-actin-GAL4]
[w+-actin-GAL80ts] [w+-UAS-roX1]) were also present. In an otherwise wild type male,
the y+ reporter in KV20 produces a few spots of abdominal pigment, but suppression of
PEV in roX1ex33A roX2∆ males leads to heavily pigmented abdomens (Fig. 4.2 A).
Flies were reared at 17˚C and timed collections of embryos were heat shocked
for 30 min at 37˚C

before the initiation of dosage compensation (1.5-3 h), after

establishment of dosage compensation (4-6 h), mid embryogenesis (10-12 h), and

45

during the final stages of cell division (12-14 h). To our surprise, non-heat shocked
controls carrying the inducible roX1 system had fully restored PEV (Fig. 4.2 C). In
contrast, flies grown in parallel that lacked the inducible roX1 system suppressed PEV
(Fig.4.2 C, left). We conclude that leaky roX1 expression is adequate to restore PEV in
flies carrying this transgene system. However, neither leaky expression nor a single 30
min heat shock during embryogenesis rescued males with the roX1smc17A roX2∆
chromosome, which is over 99% male lethal, to adulthood (Fig.4.2 C, inset).

To

determine whether this transgene system is capable of rescuing male survival we
administered daily 30 min heat shocks to roX1smc17A roX2∆; [w+-actin-GAL4] [w+-actinGAL80ts] [w+-UAS-roX1]/+ cultures and achieved 80% adult male emergence (Fig. 4.3).
This demonstrates that roX1 expression from this system is capable of rescuing dosage
compensation, but requires sustained expression. We conclude that the levels of roX
RNA required for restoration of PEV and rescue of roX1 roX2 male survival are
strikingly different.
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Figure 4.2. Position effect variegation (PEV) as a reporter for roX1 regulation of
heterochromatin.
A) The roX1ex33A roX2∆ chromosome is a potent suppressor of PEV. The y+ marker in
the KV20 insertion is largely silenced in control males with a wild-type roX1 gene (right).
Suppression of PEV leads to increased pigmentation in adult escapers carrying a partial
loss of function roX1 mutation (roX1ex33A roX2∆/Y; KV20/+).
B) Genetic assay to determine the critical time for roX in heterochromatin silencing.
roX1ex33A roX2∆ ; KV20/+ with a heat shock inducible roX1 transgene system ([UASrox118] [Tub-GAL4] [GAL80ts]) (KELLEY et al. 2008). Adult male escapers are scored for
abdominal pigmentation.
C) The inducible transgene system rescues PEV, but not male survival, in the absence
of heat shock. Staged collections of embryos reared at 17˚C were given a single heat
shock (37˚C, 30 min) at times shown on the X-axis. The survival of adult males (right)
and abdominal pigmentation (left) was determined. Control flies were not heat shocked
or lack the inducible roX1 transgene system (left). Box plots were generated using R.
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Figure 4.3. Rescue of male lethality by roX1 expression requires multiple
inductions. The inducible transgene system is capable of partial rescue of roX1SMC17A
roX2∆ males when induced daily throughout development. roX1SMC17A roX2∆ virgins
were crossed to wild type (yw) males carrying inducible transgene ([UAS-rox118] [TubGAL4] [GAL80ts]) on the 3rd chromosome (KELLEY et al. 2008). All sons will inherit
roX1SMC17A roX2∆ X chromosome and are expected to have ~ 0% male survival. Half of
the males will inherit the inducible roX1 transgene. Collections of embryos reared at
17˚C were given a heat shock (37˚C, 30 min) every day. The survival of adult males
was determined by (males/females)2. Control flies were not heat shocked (None).
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roX1 deletions differentially affect dosage compensation and heterochromatic
silencing
The finding that extraordinarily low levels of roX1 served to restore PEV raised
the question of whether there are also regions of roX1 that play differential roles in
these processes. To address this, deletions of roX1 and mutated transgenes were
tested in parallel for restoration of PEV in roX1ex33A roX2∆/Y; KV20/+ males, and for
rescue of roX1SMC17A roX2∆ male survival. As expected, expression of an intact roX1
cDNA (roX1+) fully rescues male survival and restores PEV (Fig. 4.4 B, C). Antisense
expression of the same cDNA (roX1AS) largely restores PEV and provides a minor
increase in survival, suggesting that internal promoters in the cloned fragment may
produce low levels of roX1 transcript. The roX1 gene has three main transcription start
sites, two of which are internal to the cDNA used here (STUCKENHOLZ et al. 2003). As
previously demonstrated, separating the 5' and 3' ends of roX1 abolishes rescue of
roX1 roX2 males (Fig. 4.4 C; (STUCKENHOLZ et al. 2003)). Neither fragment is able to
restore PEV, revealing that the heterochromatic role of roX also requires both domains
(Fig. 4.4 B). A roX1 transgene with a 2.4 kb internal deletion (roX17B) achieves minor
rescue of male survival, but is unable to restore PEV (Fig. 4.4 B, 4.4 C; (DENG et al.
2005)). The roX1∆6 transgene, a deletion of 325 bp within the roX1ex33 deleted region
achieves good rescue of roX1 roX2 male survival (Fig. 4.4 C; (STUCKENHOLZ et al.
2003)).

However, roX1∆6 was unable to restore PEV, suggesting that the region

removed is important for heterochromatin function (Fig. 4.4 B). The roX1∆10 carries a
349 bp 3' deletion removing a stem loop that is essential for dosage compensation
(STUCKENHOLZ et al. 2003). Neither male lethality nor PEV are restored by roX1∆10,
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indicating that this region contributes to both functions (Fig. 4.4 B, C). The roX1
transgene carries a mutation that disrupts base pairing in the stem.
demonstrated, roX1

3'SLC

3'SLC

As previously

does not rescue male survival, but this transgene effectively

restores PEV (Fig. 4.4 B, C). Taken together, these studies indicate that dosage
compensation and PEV both require 5’ and 3’ elements of the roX1 transcript, but the
precise 3’ regions required differ for these two processes. Deletions of the central
portion of roX1 preferentially affect PEV.
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Figure 4.4. Mutations separate the compensation and heterochromatin functions
of roX1.
A) roX1 regions previously identified for their role in dosage compensation and MSL
binding are depicted above the transgenes tested for restoration of PEV and rescue of
lethality. Stem loops 1 and 2 (SL1, 2 (STUCKENHOLZ et al. 2003; KELLEY et al. 2008)),
roXboxes 1, 2 and 3 (RB1, 2, 3 (FRANKE and BAKER 1999; KELLEY et al. 2008; PARK et
al. 2008)), inverted roXbox (IRB) and binding profiles of MSL2 and MLE (MSL2, MLE
(ILIK et al. 2013; MAENNER et al. 2013)) are depicted. Regions of roX1 that are
exclusively required for PEV are depicted in red. All transgene constructs are driven by
the hsp83 promoter. roX13'SLC is a mutation (black vertical line) that disrupts base
pairing of the stem of stem loop 1 (also called SLroX1 or R1H1; (KELLEY et al. 2008; ILIK
et al. 2013)). roX1∆6, roX1∆10 and roX13'SLC are described in (STUCKENHOLZ et al. 2003).
roX17B is described in (DENG and MELLER 2009). Numbering is with respect to that used
in (AMREIN and AXEL 1997). roX1 deletions roX1ex33A and roX140A are shown at the
bottom.
B) The number of abdominal spots in roX1ex33AroX2∆ flies carrying each roX1 transgene
and KV20. Box plots were generated using MatLab.
C) Transgenes were tested for rescue of the severe roX1SMC17AroX2∆ chromosome
(gray bars). The percent male survival, calculated by the number of males divided by
the total number females, is shown on the Y-axis. roX1 roX2 males without transgenes
were the controls.
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MSL3 binds at autosomal sites during embryogenesis.
How roX RNA and MSL proteins contribute to heterochromatic silencing remains
unclear. Following MSL2 expression, at 3 h AEL, an intact complex composed of five
MSL proteins and roX RNA localizes to X chromatin. The strikingly exclusive binding of
these proteins suggests that they are unlikely to associate with autosomal sites during
the later stages of development. However, it is possible that maternally provisioned
MSL proteins could localize to autosomal sites during early embryogenesis.

If this

occurs, the MSL proteins might be detectable at these sites.
To test this idea we used ChIP to examine MSL3 localization in timed collections
of control embryos (yw laboratory reference strain), and embryos lacking maternal
MSL1. Both MSL1 and MSL3 have been shown necessary for heterochromatic gene
expression, suggesting that they might colocalize at affected genes (DENG et al. 2009).
MSL1 serves as the scaffold for assembly of the MSL complex, and it is essential for all
X chromosome binding (LI et al. 2005). Importantly, although MSL3 levels remain high
in msl1 mutants, MSL3 protein is no longer bound to chromatin (GORMAN et al. 1995;
KADLEC et al. 2011). Zygotic expression of MSL1 initiates during stage 11 (5.2 to 7.2 h),
so very young embryos from msl1 mothers lack MSL1 protein (RASTELLI et al. 1995).
Staged collections of 1.5 to 3 h embryos (before dosage compensation) and 4 to 6 h
(after the initiation of compensation) were generated and subjected to ChIP.
ChIP-qPCR analysis of wild type 1.5 to 3 h embryos revealed widespread
enrichment of MSL3 at euchromatic and heterochromatic genes on all chromosomes (X,
2, 3 and 4: Fig. 4.5 A, black bars). Enrichment was observed in every gene examined,
regardless of location or chromatin type, and was eliminated in embryos from msl1/msl1

55

mothers (Fig. 4.5 A, gray bars). The dependence of MSL3 enrichment on MSL1 at
autosomal sites supports the idea that these proteins form a complex that localizes to
these regions during early embryogenesis.
Between 4 and 6 h (stages 9 - mid 11) males have established dosage
compensation. ChIP analysis of control 4 to 6 h embryos reveals continued enrichment
of MSL3 at autosomal genes, and intensified binding at X-linked sites (Fig. 4.5 B, black
bars). Older embryos from msl1 mothers will have initiated zygotic MSL1 expression.
As anticipated, MSL3 localization is largely restored at X-linked genes in embryos from
msl1/msl1 mothers (Fig. 4.5 B, gray bars). Interestingly, MSL3 binding to autosomal
genes is also largely restored in these older embryos. Taken together, ChIP studies
reveal that MSL3 is broadly localized throughout the genome of early embryos, and that
this localization is dependent on MSL1.
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Figure 4.5. MSL3 binds throughout the genome during early embryogenesis.
Chromatin Immunoprecipitation (ChIP) was used to determine enrichment of MSL3 in
different genomic regions of embryos from wild type mothers (dark gray), and msl1
mothers (light gray). Chromatin was prepared from collections of 1.5-3 h AEL (A) and
4-6 h AEL (B) embryos. Standard error was generated from biological replicates (1.5 to
3 h AEL) or technical replicates (4-6 h AEL). Genes were grouped into euchromatic
autosomal (chromosomes 2, 3), X-linked, heterochromatic (chromosomes 2, 3) and 4th
linked.
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Discussion
Conserved MSL complex family.
The MSL proteins were first identified by their role as dedicated regulators of the
male X chromosome (Table 4.1; (LUCCHESI 1998)). MSL1 acts as a scaffold for binding
of MSL2, MSL3 and MOF (HALLACLI et al. 2012). Dimerization of MSL1 is essential for
dosage compensation, and intact complexes are presumed to contain two molecules of
MSL1, MSL2, MLS3 and MOF (LI et al. 2005; HALLACLI et al. 2012; LIM and KELLEY
2012). A single roX molecule is present in each complex and the stoichiometry of MLE,
thought to associate with the complex through roX, is presently unknown (ILIK et al.
2013). The role of the Jil-1 kinase, which has been linked to X chromosome dosage
compensation and maintenance of the heterochromatin/euchromatin balance in the cell,
remains ambiguous (JIN et al. 2000; LERACH et al. 2005). In spite of reports that Jil-1
contributes to full expression of X and 4th-linked genes in S2 cells, we see no evidence
of this in larvae (REGNARD et al. 2011).
Throughout the eukaryotes, homologues of the MSL proteins have been found in
complexes that participate in chromatin organization, DNA repair, gene expression, cell
metabolism and neural function (EISEN et al. 2001; MARIN 2003; SMITH et al. 2005).
Indeed, flies contain a distinct complex, the Non-Sex specific Lethal (NSL) complex,
which contains MOF and homologues of several MSL proteins (NSL1, NSL2 and NSL3;
(MENDJAN et al. 2006; CAI et al. 2010; RAJA et al. 2010). The essential NSL complex is
broadly associated with promoters throughout the fly genome, where it acetylates
multiple H4 residues (CAI et al. 2010; RAJA et al. 2010; FELLER et al. 2012; LAM et al.
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2012). Excepting roX RNA and MLE, homologues of all MSL complex members have
been identified in yeast and humans, suggesting that acquisition of roX RNA and MLE
may have enabled recruitment of the complex to dosage compensation (SMITH et al.
2005; TAIPALE et al. 2005; CAI et al. 2010). In light of the fact that the MSL proteins
represent an ancient lineage of chromatin regulators, it is unsurprising that members of
this complex have been implicated in additional functions.
The X compensation and heterochromatin functions of roX1 are separable.
Although roX1 RNA participates in two male-limited processes, dosage
compensation and heterochromatin integrity, these are to some extent genetically
separable. First, low levels of roX1 RNA produced by a heat-inducible system in the
absence of heat shock are sufficient to completely rescue heterochromatic silencing, but
not compensation (see figure 3A 6 in (KELLEY et al. 2008)). Second, we have identified
roX1 mutations that differentially influence these two processes.
Elegant, high resolution studies reveal that MLE and MSL2 bind roX1 directly,
and the regions bound by these proteins are essentially indistinguishable (ILIK et al.
2013; MAENNER et al. 2013). Three prominent peaks of MLE/MSL2 binding have been
identified, one overlapping a 3’ stem loop that is essential for roX1 function
(STUCKENHOLZ et al. 1999). The stem loop incorporates a 30 bp consensus “roX box”
sequence conserved between D. melanogaster roX1 and roX2, and also present in roX
RNAs in related species (FRANKE and BAKER 1999; STUCKENHOLZ et al. 2003; PARK et
al. 2007; KELLEY et al. 2008). A possible explanation for the concurrence of MLE and
MSL2 binding is that MLE, an ATP-dependent RNA/DNA helicase, first binds to and
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remodels stem loops, permitting MSL2 binding within the remodeled regions (LEE et al.
1997; MAENNER et al. 2013). Two out of three peaks of MLE/MSL2 binding are removed
by a 2.3 kb roX1 deletion, roX1ex40A, which supports full male survival with virtually no
effect on localization of the MSL complex, emphasizing the internal redundancy of roX1
for dosage compensation (DENG et al. 2005; MENON and MELLER 2012). Interestingly,
while both proteins are essential for dosage compensation, MSL2 it is not involved in
heterochromatic gene regulation (DENG et al. 2009). We find that base pairing within
the 3’ roX1 stem loop is required for compensation but not for heterochromatic
silencing. However, deletions that remove the stem-loop and surrounding regions are
unable to restore PEV in roX1 roX2 mutants, indicating additional functional elements in
the 3' end. Furthermore, the roX1∆6 cDNA, created by removing 325 bp within the
roX1ex33 deleted region, largely restores dosage compensation but fails to restore PEV.
Taken together, these studies reveal regions of roX1 that are essential for PEV, but are
non-essential, or redundant, for dosage compensation (PEV exclusive in Fig. 4.4 A).
These observations provide a potential role for some of the secondary structures found
in roX1, but not yet implicated in dosage compensation (ILIK et al. 2013; MAENNER et al.
2013).
What is the role of this complex in heterochromatin formation?
A central question raised by this study is how a group of proteins that are known
for their role in activation of the X chromosome also regulate heterochromatin.
Expression of heterochromatic genes is thought to require distinct factors that overcome
heterochromatic silencing (YASUHARA and WAKIMOTO 2006). It is possible that roX RNA
and a subset of MSL proteins participate in this process.

This would explain why
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heterochromatic genes are particularly sensitive to the loss of factors with broad
localization throughout the genome during early embryogenesis.

Conversely, it is

possible that H4K16 acetylation is required for normal heterochromatin assembly. In
support of this idea, H3K4 and H4K16 acetylation participate in formation of
heterochromatin in yeast (XHEMALCE and KOUZARIDES 2010; OPPIKOFER et al. 2011).
Active deacetylation of H4K16ac is necessary for spreading of chromatin-based
silencing (OPPIKOFER et al. 2011). As MOF is responsible for the majority of H4K16ac in
the fly, a MOF-containing complex could fulfill a similar role in flies. In our study the
effect of MOF was limited to genes on the 4th chromosome. This distinction is interesting
in light of numerous studies finding that heterochromatin of the 4th chromosome is
genetically and biochemically different from that on other chromosomes (RIDDLE et al.
2011; RIDDLE et al. 2012).

For example, Su(var)3-9 introduces H3K9me in other

regions of the genome, but SETDB1 deposits this mark on the 4th chromosome (SEUM
et al. 2007). Furthermore, the Painting of Fourth (POF) protein localizes exclusively
along the 4th chromosome, where it binds cooperatively with HP1a, a key
heterochromatic component (LUNDBERG et al. 2013). While we observed a general
reduction in expression of autosomal heterochromatic genes in roX1 roX2 males, those
on the 4th chromosome were most severely affected (DENG et al. 2009). In summary,
our findings support the idea that heterochromatin on the 4th chromosome is unusual,
and this is reflected in the expression of 4th linked genes in roX mutant backgrounds.
An intriguing question raised by this study is what limits this process to males. A
direct correlation between the amount of heterochromatin in the genome to the degree
of heterochromatic silencing has been established (GIRTON et al. 2013). As the large,
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heterochromatic Y chromosome is only present in males, it is possible that additional
heterochromatin in the male nucleus has given rise to a compensatory regulatory
mechanism. Still unexplained, and the subject of ongoing investigation, is what limits
this process to males.
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Table 4.1 Orthologs of the Drosophila MSL complex function in different species.
Conserved proteins are shown in same column.
Complex

MSL

NSL24

hMSL20,23

Tip6022

NuA421,22

Organism
Substrate

Fly
H4K16Ac1

Fly
H4K16Ac4,
H4K5 & K8
Ac5,H3K4me26

Human
H4 K16 Ac8,
H2B K34 ub9
p5310

Yeast
H4, H2A13

Subunits

MOF
-

MOF
-

hMOF
-

Human
H2A K515, H2AX K5
Ac16, H3 K1415
H4 K4, K5, K8, K12,
K1615, p5317,
Non-histone
proteins18
Tip60
TRRAP
actin
BAF53
EPCc

MSL3
MLE
MSL1
MSL2
roX RNA
Dosage
compensation2,
modulation of
male
heterochromatin
genes3.

NSL3
NSL1
NSL2
MCRS2
MBD-R2
WDS
Regulation of
housekeeping
gene expression7

hMSL3L1
hMSL1v1
hMSL2
Regulation of
transcription11,
DNA damage
response, DNA
repair, Cell
growth12.

-

Eaf3
Yng2
Eaf1
Eaf2
Eaf5
Yaf9
Eaf6

Function

p400
Tip49
Tip48
Metabolism18, Cell
death and apoptosis,
DNA repair16,17,
Neural development
and behavior19.

Esa1
Tra1
Act1
Arp4
Epl1

Chromatin
remodeling,
regulation of
transcription
13,
DNA repair14
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(GELBART et al. 2009), 2 (GELBART and KURODA 2009), 3 (DENG et al. 2009), 4 (RAJA et

al. 2010), 5(CAI et al. 2010), 6(ZHAO et al. 2013), 7(RAJA et al. 2010; FELLER et al. 2012;
LAM et al. 2012), 8(SMITH et al. 2005), 9(W U et al. 2011), 10(CHANG et al. 2013), 11(GUPTA
et al. 2005; SMITH et al. 2005; TAIPALE et al. 2005; SYKES et al. 2006), 12(REA and
AKHTAR 2006), 13(SMITH et al. 1998; CLARKE et al. 1999), 14(BIRD et al. 2002),15(KIMURA
and HORIKOSHI 1998), 16(IKURA et al. 2007), 17(SYKES et al. 2006; TANG et al. 2013),
18

(SAPOUNTZI et al. 2006), 19(TEA and LUO 2011), 20(SMITH et al. 2005), 21 (EISEN et al.

2001), 22 (HILFIKER et al. 1997), 23 (NEAL et al. 2000), 24 (MENDJAN et al. 2006; RAJA et al.
2010),
Experimental Procedures
Fly strains and culture.
Flies were maintained at 25˚C on cornmeal agar diet in a humidified incubator.
Descriptions of mof1, mof2, mle1 and Jil-1z2 can be found in (FUKUNAGA et al. 1975;
HILFIKER et al. 1997; GU et al. 1998; W ANG et al. 2001). The p[SUP or-P] insertion
KV0020 is described (KONEV et al. 2003). The [w+ actin-GAL4] [w+-actin-GAL80ts] [w+UAS-roX1] third chromosome is from (KELLEY et al. 2008). Mutant roX1 transgenes
roX1+, roX1AS, roX1∆6, roX1∆10, roX1

3'SLC

and roX17B are described in (MELLER et al.

2000; STUCKENHOLZ et al. 2003; DENG and MELLER 2008).
Quantitative PCR (qPCR)
qRT PCR was performed essentially as described (DENG et al. 2009). Dmn, on
all plates, and ytr, on all plates excepting mof assays, were used for normalization. mof
was normalized using Dmn and an average of ytr values from the same template.
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Collection of embryos and chromatin preparation.
Collection of embryos and chromatin preparation was performed as described in
(MARTINEZ and ARNOSTI 2008) with few exceptions. In brief, 0.5 g of embryos was
added to 9.2 ml cross linking buffer (50 mM HEPES [pH 7.6], 1 mM EDTA, 0.5 mM
EGTA, 100 mM NaCl), 0.81 ml of 37% formaldehyde (Fisher Scientific cat number
BP531) and 30 ml of n-heptane. Samples were shaken vigorously for 20 min in a 50 ml
conical tube, centrifuged for 1 min at 2,000 g and the supernatant discarded. Cross
linking was stopped by adding 25 ml 0.125 M glycine with 0.01% Triton X-100 in
phosphate-buffered saline (1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4, 18 mM
KH2PO4, [pH 7.4]) and vigorously shaken for 30 min. Tubes were centrifuged at 2000g
for 1 min, supernatant discarded and the fixed embryos were immediately processed for
chromatin or flash frozen and stored at -80°C.
Five hundred mg of fixed embryos were washed in 10 ml of embryo wash buffer
(10 mM HEPES [pH 7.6], 1 mM EDTA, 0.5 mM EGTA, 0.1% sodium deoxycholate with
0.02% sodium azide) for 10 min with vigorous agitation, centrifuged at 2,000 g, and
embryos resuspended in 5 ml of sonication buffer (10 mM HEPES [pH 7.6], 1 mM
EDTA, 0.5 mM EGTA and 0.1% Triton X-100), and a proteinase inhibitor tablet added
(Roche Complete Mini Cat no# 04693124001).
Sonication was done on ice using a Fisher Model 500 Sonic Dismembrator and a
3.2 mm micro tip at 35% amplitude for 70 cycles of 30 sec pulse and 59 sec cooling
(total of 105 min). Sonicated material was centrifuged for 15 min at 16000 g to remove
debris. Supernatants were mixed with an equal volume of 2X radio-immunoprecipitation assay (RIPA) buffer (2% Triton X-100, 280 mM NaCl, 20 mM Tris-HCl [pH
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8.0], 2 mM EDTA, 0.2% sodium dodecyl sulfate) with 1 tablet of protease inhibitor for
the entire volume and precleared with Protein G Agarose beads (Pierce Thermo
Scientific Cat no# 20398) that had been washed three times with RIPA buffer and
blocked with 0.2 µg /µl salmon sperm DNA and 0.1 µg /µl BSA for 30 min at room
temperature. Blocked beads were added (10 µl/ml) and gently agitated for 30 min at
4˚C. One ml aliquots of the cleared supernatant were flash frozen and stored at -80˚C.
Chromatin immunoprecipitation.
Chromatin

immunoprecipitation

was

performed

essentially

as

described

(MARTINEZ and ARNOSTI 2008) with the following exceptions. All steps were performed
at 4˚C with ice cold buffers unless otherwise noted. Two hundred fifty µl of chromatin,
250 µl RIPA buffer and 25 µl of anti-MSL3 antibody (gift of M. Kuroda) were gently
mixed overnight in 1.5 ml tubes and centrifuged at 16000 g for 5 min. Supernatants
were transferred to a new tube containing 40 µl of blocked protein G beads and gently
mixed for 2 h. The beads were gently pelleted at 80 g and washed three times with low
salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-Cl [pH 8.0] and 150
mM NaCl), three times with high salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris-Cl [pH 8.0], 500 mM NaCl), once with LiCl buffer (0.25 M LiCl, 1% NP-40,
1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-Cl [pH 8.0]) and twice with TrisEDTA (10 mM Tris [pH 8.0], 1 mM EDTA).

Chromatin was eluted by two 15 min

washes with 250 µl of freshly prepared elution buffer (1% SDS, 0.1 M monobasic
NaHCO3 [pH 8.0]) at room temperature. Input was obtained by mixing 25 µl of precleared chromatin and 475 µl of elution buffer. Input and eluted chromatin were reverse
cross linked by overnight incubation at 65˚C in 0.2M NaCl, followed by RNase digestion
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(10µg of RNAse) for 30 min at 37˚C and Proteinase K digestion (20 µg for Proteiase K)
for 2 hrs at 42˚C.

DNA was phenol chloroform extracted and ethanol precipitated.

Washed pellets were resuspended in 50 µl of distilled water and stored at -20˚C.
ChIP-qPCR analysis.
Input and ChIP DNA fractions were diluted fivefold for use as qPCR templates.
Duplicate 20 µl reactions contained 10 µl of BioRad iTaq Fast SYBR Green supermix
with ROX (Cat no#172-5101), 4 µl of template, 4 µl of 300 nM primer mix and 2 µl of
distilled water. Amplification was performed using a Stratagene Mx3000P Real-Time
PCR system by initial denaturation for 3 min at 95˚C and 40 cycles of denaturation
(95˚C, 3 sec), annealing (55˚C, 30 sec) and extension (72˚C, 30 sec). Data analysis
was done by the ∆Ct method (LIVAK and SCHMITTGEN 2001; SABIOSCIENCES 2008).
Input Ct values were corrected for dilution (Ct

[dilution corrected Input]

= Ct

[Input]-

Log2 (Input

Dilution Factor)) where Input dilution factor = (fraction of the input chromatin saved)-1.
Ct values from ChIP were normalized to the dilution corrected Input DNA Ct values (∆Ct
[normalized ChIP]=

Ct

[ChIP]-

Ct

[dilution corrected Input]).

Normalized ∆Ct values were converted to

percent of Input (% Input = 2 -∆Ct [normalized ChIP] ). Genes analyzed are in APPENDIX I.
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Chapter 5
Summary and Perspectives
Drosophila dosage compensation is a classical model for epigenetic regulation.
While the activity of the MSL complex was traditionally thought to be limited to the male
X chromosome, our research revealed that a subset of complex members perform
additional autosomal functions, but only in males (DENG et al. 2009).

These

observations had strong genetic support, but no studies addressed the molecular basis
of these autosomal functions. My work determined which proteins of the MSL complex
participated in autosomal regulation (Chapter 3 and 4). I went on to demonstrate that
one of these proteins, MSL3, physically localizes throughout the genome, in an MSL1dependent manner, during early embryogenesis (Chapter 4). Finally, my studies of
roX1 mutants and deletions revealed that there is a region of the roX1 RNA that is not
required for dosage compensation, but is necessary for epigenetic silencing by
autosomal heterochromatin (Chapter 4). While these studies support the idea that a
subcomplex composed of roX RNA and several MSL proteins acts directly at autosomal
sites, several questions remain.
Is MSL3 localization dependent on roX RNA?
In dosage compensation, roX RNA is required for exclusive targeting of the MSL
complex to the male X chromosome (MELLER and RATTNER 2002; DENG et al. 2005;
DENG and MELLER 2006).

I have demonstrated that roX RNA and subset of MSL

proteins are required for full expression of heterochromatic genes, and that MSL3
localizes to the autosomes in early embryos.

However, we have not demonstrated a
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roX requirement for targeting of MSL3 to these autosomal sites.

This could be

addressed by performing ChIP of MSL3 in wild type and roX1 roX2 embryos. This
study would clarify the role of roX RNA in targeting of MSL proteins to different locations
on genome, and could explain the heterochromatin requirement for roX.
Is autosomal chromatin modified by the MSL subcomplex?
My findings raise the question of how the MSL proteins, known to be involved in
activation of X-linked genes, also regulate repressive heterochromatin. In yeast, H3K4
and H4K16 acetylation is required for formation of repressive heterochromatin, and
active deacetylation of H4K16ac is necessary for spreading of chromatin-based
silencing (XHEMALCE and KOUZARIDES 2010; OPPIKOFER et al. 2011). It is possible that
the MSL proteins perform an early step in heterochromatin formation by acetylating
histones.

MOF is responsible for the majority of H4K16Ac in flies (CONRAD et al.

2012a). Direct action of a MOF-containing complex, such as we have proposed, could
in this way contribute to heterochromatin formation.

To address this, ChIP for

acetylated H3K4, H3K16 and MOF could be performed in embryos from wild type and
msl3 or msl1 mutant mothers.
Can roX1 mutations that more completely separate the dosage compensation and
heterochromatic functions be identified?
We have shown that the dosage compensation and heterochromatic functions of
roX1 RNA are at least partially genetically separable. It is possible that many of the
numerous secondary structures in roX1 RNA contribute differentially to the functions of
this molecule (ILIK et al. 2013; MAENNER et al. 2013). High resolution scanning of roX1
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RNA to identify mutants that more completely separate these two functions might be
productive. The high degree of redundancy within roX1 for dosage compensation has
made this approach unappealing.

However, our observation that the small roX1∆6

deletion fails to restore PEV suggests less internal redundancy for the heterochromatic
function.
What is the basis of differential MOF regulation of heterochromatin on different
autosomes?
We demonstrated that MOF is necessary for full expression of heterochromatic
genes on the 4th chromosome, but not on the other autosomes.

It would be good to

confirm this observation with genome-wide analysis of wild type and mof mutant male
larvae. Interestingly, numerous studies have demonstrated that heterochromatin on the
4th chromosome is unusual in its formation and protein composition (RIDDLE et al. 2011;
RIDDLE et al. 2012). This suggests that the differential effects of mof mutants may
reflect underlying features of heterochromatin itself. Further exploration of this question
may provide insight into why the 4th chromosome is so different than other autosomes.
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APPENDIX A
MSL1
Descriptive statistics for relative quantities (Ct mutant: Ct control)
Range
Gene Group

No of
genes

Mean

Minimum

Maximum

Std. Deviation

Std. Error

2&3 Euchromatic

7

1.37148

1.02

2.208

0.473859

0.179102

X chromosomal

4

0.888

0.634

1.12

0.268492

0.134246

2&3 Heterochromatic

10

0.9161

0.738

1.5

0.219706

0.069477

4th chromosomal

12

0.85038

0.566

2.03

0.394979

0.114021

MSL1 gene group comparisons

Comparision
2&3 Euchromatic Vs X
chromosomal
2&3 Euchromatic Vs 2&3
Heterochromatic
2&3 Euchromatic Vs 4th
chromosomal
a. Not corrected for ties

Mean
Diff
0.483476

Std. Error

Z score

0.224306

-1.515

Mann-Whitney U
Test
Exact Sig. [2*(1a
tailed Sig.)]
0.164

0.455376

0.17636

-2.928

0.002

0.003

0.521101

0.170201

-3.043

0.001

0.002

Asymp. Sig. (2tailed)
0.13

MSL3
Descriptive statistics for relative quantities (Ct mutant: Ct control)
Range
Gene Group

No of genes

Mean

Minimum

Maximum

Std. Deviation

Std. Error

2&3 Euchromatic

7

1.17098

0.717

1.63

0.340002

0.128509

X chromosomal

4

0.56162

0.468

0.667

0.099245

0.049622

2&3 Heterochromatic

10

0.8063

0.658

0.969

0.104504

0.033047

4th chromosomal

13

0.93238

0.557

3.01

0.647348

0.179542

MSL1 gene group comparisons
Comparision
2&3 Euchromatic Vs X
chromosomal
2&3 Euchromatic Vs
2&3 Heterochromatic
2&3 Euchromatic Vs
4th chromosomal
a. Not corrected for ties

Mean
Diff
0.6093
6
0.3646
8
0.2386

-2.646

Mann-Whitney U Test
Exact Sig. [2*(1-tailed
a
Sig.)]
0.006

Ass.Sig (2tailed)
0.008

0.21762

-2.147

0.033

0.032

0.207022

-2.1

0.037

0.036

Std.
Error
0.276784

Z score
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APPENDIX B
qRT-PCR primers.
Name

F/R

Sequence

Primer work
Conc.(nM)

Efficiency
(%)

Chromosome 2&3
Dmn
ytr
LanB1
Xbp1
Dip-B
Atp-a
GAPDH
Bigmax
CG3476

F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

X chromosome
Mgst1
F
R
Trxr-1
F
R
Mnt
F
R
yin
F
R
run
F
R
CKII
F
R
Rala
F
R

GACAAGTTGAGCCGCCTTAC
CTTGGTGCTTAGATGACGCA
ATTTTGGACCAGCACCACTC
CAAAATCCCTGCAATTTCGT
TCAACGAGCACCTGATTCAC
GCAAATGGATGTTTCCCAAT
GGGAGAGCAACTTTGACGAG
GCCGGCCAAACTTAACAATA
AGGATCACGCCAGAAGACTG
AGTCACTGGGACGGAGAATG
ACCCACACTGCTACACTCCC
TCCTGGTTGCTCTTGTTGTG
GCCCTGAACGGCAAGCT
GTAAGATCCACAACGGAGACATTG
CTCGGCGCACAATTCAGA
CCCTTCTCCGCTCCTTGTAA
GCCATCCATTGGACACAATA
GGCGGCACAATCTATGACT

300
300
300
300
300
300
300
300
300
300
300
300
300
300
400
300
300
300

CCCAAGCTGAAGGTCAAGTT
CGGATCAGTCAGGACGTAGA
ATCACCAGCGATGATCTGTT
AATCCAGCGCACTCCAAG
GGGAATAGGAGCCACAACTG
ACTGAACCTCCGCCAGCTGG
GGTGATTGCCGAATTCAAGT
ACTAGCATAAGGCTGGCGAA
CACGGGAGCCAAGAAGTAAG
TTCAGCATGAACGGGTTAAA
CCTGGTTCTGTGGACTTCGT
GTAGTCCTCATCCACCTCGC
CAAGCTTTGGAGACTTTCCG
GTGTTCCAGGGCAAAGAAAA

300
300
500
500
100
100
300
300
500
500
300
300
300
500

98.5
90.6
94.5
97.1
92.8
106.3
98.9
97.6
103.8

94.6
101.2
109.7
110.4
97.7
98.4
110.7
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Name
Sgs4

F/R

F
R
Pgd
F
R
BR-C
F
R
skpA-RA
F
R
PpV-RA
F
R
CG1702-RA
F
R
CG9066-RA
F
R
4th chromosome
Arc70
F
R
cals
F
R
Ephrin
F
R
plexA
F
R
CG17923
F
R
RfaBp
F
R
Eph
F
R
CG11077
F
R
pho
F
R
plexB
F
R
Rad23
F
R
Crk
F

Sequence
GAAGGACCTGCTAACACCGA
ATTTACACTTGGGTGCAGGC
TGCTGGTCAAGGCTGGAAGT
GAGATGTGTCCTGATACTCCGAGTT
CTCAAGAGCACACCCTGCAA
CGTGCAGGTCCATGAAGTTG
CTAAAAGTCGACCAGGGCAC
CCAGATAGTTCGCTGCCAAT
TTGACCACCCATGAACTCAA
GTGTTTGCTATGCTTGGGGT
GACATCTTTGCAGCCTGTGA
GCCCTGATCTTGGGGTACTT
TGCTTTTGGATGTGGCTGTA
TAAAGGAGCAGAGGCAGCAT
ATCGTACAACAACGAGCCCT
CAGCGTGAAAGAAACGTCAA
AGTTTGTCAGCCCTCACCTT
CTCCTATGCATTGCGACAGA
TTGCAATTCTTGGCATTCAC
CATAGAGGTCGCGGTGATTT
AAAGCAGCGATTGGCTTTTA
GGCGCAGCTCTTATTCTGAC
CCCCCTCCAGACTTAAAGGA
CCATTCTTGTCCGTAGCCAT
ACTGTCGCTGTCTTCCGATT
GATTTTGCCTTTTTGTTCGC
CTACCGTTTACCAGCTCCGA
TTGCCAGCAATCCAACATTA
GCCCTCGTATGGAACTGCTA
CCGTATTACTTATGCGGGGA
TCACGCAAAAGCAAAGAGAA
ATTCAGCGTTTGAACAACCA
AACGGAACCACAAAAGATCG
ATGTTACCGAGCGAACCAAC
GCGGATAACGAAGACTTGGA
TAGCCGTTCTATTGCGTCCT
AACATTAATGGGCAATGGGA

Primer work
Conc.(nM)
300
300
100
100
300
300
300
300
300
300
300
300
300
300
300
300
500
500
300
300
500
500
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300

Efficiency
(%)
101.3
110.7
101.2
90.4
94.2
92.7
92.3

86.4
89.2
95.2
86
94.1
88
93.6
87.5
88.6
98.8
99
92.6
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Name

F/R

Sequence

R
CATCGACAAATTCAACGTGC
unc-13
F
GCGTTGGACGACTTAGCTTC
R
CATGTCTCCAAGTTCTCGCA
Ank
F
TGCAGAGTTTGGCACTCATC
R
TCGCCATCTTTTTCAATTCC
Mav
F
GATAAAATCGACGAGGCCAA
R
TTTTCCTAGATCCTGGCCCT
Chromosome 2 & 3 Heterochromatic
lt
F
CGAAGCTTCAACTGGCAATC
R
AGATAATGGTGCAAGCCCAC
CG17540
F
TCGAAAGTGCAATTAAAGCTG
R
TAGTTGTAAAACCCCGCTCG
CG40439
F
TCTCGAGCATTGGGAGTTCT
R
TGCCTTCCAAAGCTGCTATC
CG17665
F
GCAGAAGCAATAGCCGAATC
R
AAACGCCTCCCAAGTGTATG
CG17683
F
AGGACTTTTTCAGCAAGGCA
R
TGCTGAGCCTCACTAAGCAA
Gprk1
F
TCTAAAAGGCTTGGGTGCAT
R
TGTAAACCTGGTGCCAATCA
CG12547
F
TTTTCCCGCAAAGATTGTTC

Rad21
MED21
CG41099

R
F
R
F
R
F
R

CCCCGTATCAGCAATAGCAT
CCCAGAACCACCTTCGTAGA
GGACTGTGAAGGCATTGGTT
GGAAGTAGTGCAAAAAGGCG
TGAGCAATGCATTCCAAAGA
GTGCGACATGGAATTGACAC
CAATTGCGCGATGTAAAAGA

Primer work
Conc.(nM)
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300

Efficiency
(%)
99.9
100.1
104.4

94.5
97.1
98.3
97.2
98
97.2
96.3

94.7
91.5
87.6
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APPENDIX C

Collection of embryos and chromatin preparation.
Collection of embryos and chromatin preparation was performed essentially as
described in (MARTINEZ and ARNOSTI 2008). In brief, control (yw) and test (msl32)
embryos were collected for 1.5 h or 2 h on to molasses plates (2.1% bacteriological
agar [cat no# AC443570050, Fisher Scientific], 10% unsulphured molasses [B&G foods
Inc, Grandma's]) with yeast paste (Lesaffre Red Star active dry yeast, Vacuum pack) on
the edges, and were aged to obtain staged populations. Molasses plates containing
embryos were stored temporarily at 4°C until to obt ain sufficient amount of embryos for
cross linking.
Embryos were washed into nylon mesh using embryo wash buffer 1 (0.3% Triton
X, 0.4% Nacl, 10mM Tris HCl [pH7.0]) followed by cold tap water. Embryos were
dechorionated using 50% commercial bleach and were washed again in cold water for 1
minute. This entire process was completed in less than 20 min and embryos were kept
on ice as much as possible.
Five hundred mg of embryos was added to 9.2 ml cross linking buffer (50 mM
HEPES [pH 7.6], 1 mM EDTA, 0.5 mM EGTA, 100 mM NaCl), 0.81 ml of 37%
formaldehyde (Fisher Scientific cat number BP531) and 30 ml of n-heptane. Samples
were shaken vigorously for 20 min in a 15 ml conical tube, centrifuged for 1 min at 2,000
g and the supernatant discarded. Cross linking was stopped by adding 25 ml 0.125 M
glycine with 0.01% Triton X-100 in phosphate-buffered saline [1.37 M NaCl, 27mM KCl,
100 mM Na2HPO4, 18mM KH2PO4, pH 7.4] and vigorously shaken for 30 min. Tubes
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were centrifuged at 2000 g for 1 min, supernatant discarded and the fixed embryos
were immediately processed for chromatin or flash frozen and stored at -80°C.
Five hundred mg of fixed embryos were washed in 10 ml of embryo wash buffer
(10 mM HEPES [pH 7.6], 1 mM EDTA, 0.5 mM EGTA, 0.1% sodium deoxycholate with
0.02% sodium azide) for 10 min with vigorous agitation, centrifuged at 2,000 g for 1 min,
and embryos resuspended in 5 ml of sonication buffer (10 mM HEPES [pH 7.6], 1 mM
EDTA, 0.5 mM EGTA and 0.1% Triton X-100), and a proteinase inhibitor tablet added
(Roche Complete Mini Cat no# 04693124001).
Sonication was done on ice using a Fisher Model 500 Sonic Dismembrator and a
3.2 mm micro tip at 35% amplitude for 70 cycles of 30 sec pulse and 59 sec cooling
(total of 105 min). Sonicated material was centrifuged for 15 min at 16000g to remove
debris.

Supernatants were mixed with an equal volume of 2X radio-immuno-

precipitation assay (RIPA) buffer (2% Triton X-100, 280 mM NaCl, 20 mM Tris-HCl [pH
8.0], 2 mM EDTA, 0.2% sodium dodecyl sulfate) with 1 tablet of protease inhibitor for
entire volume and precleared with Protein G Agarose beads (Pierce Thermo Scientific
Cat no# 20398) that had been washed three times with RIPA buffer and blocked with
0.2 µg /µl salmon sperm DNA and 0.1 µg /µl BSA for 30 min at room temperature.
Blocked beads were added (10 µl/ml) and gently agitated for 30 min at 4˚C. One ml
aliquots of the cleared supernatant were flash frozen and stored at -80˚C.
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APPENDIX D

Chromatin immunoprecipitation
Chromatin

immunoprecipitation

was

performed

essentially

as

described

(MARTINEZ and ARNOSTI 2008) with the following exceptions. All steps were performed
at 4˚C with ice cold buffers unless otherwise noted. Two hundred fifty µl of chromatin,
250 µl RIPA buffer and 25 µl of anti-MSL3 antibody (gift of M. Kuroda) were gently
mixed overnight in 1.5 ml tubes and centrifuged at 16000 g for 5 min. Supernatants
were transferred to a new tube containing 40 µl of blocked protein G beads and gently
mixed for 2 h. The beads were gently pelleted at 80 g and washed three times with low
salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-Cl [pH 8.0] and 150
mM NaCl), three times with high salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris-Cl [pH 8.0], 500 mM NaCl), once with LiCl buffer (0.25 M LiCl, 1% NP-40,
1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-Cl [pH 8.0]) and twice with TrisEDTA (10 mM Tris [pH 8.0], 1 mM EDTA).

Chromatin was eluted by two 15 min

washes with 250 µl of freshly prepared elution buffer (1% SDS, 0.1 M monobasic
NaHCO3 [pH 8.0]) at room temperature. Input was obtained by mixing 25 µl of precleared chromatin and 475 µl of elution buffer. Input and eluted chromatin were reverse
cross linked by overnight incubation at 65˚C in 0.2M NaCl, followed by RNase digestion
(10µg of RNAse) for 30 min at 37˚C and Proteinase K digestion (20µg for Proteiase K)
for 2 hrs at 42˚C.

DNA was phenol chloroform extracted and ethanol precipitated.

Washed pellets were resuspended in 50µl of distilled water and stored at -20˚C.
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APPENDIX E
ChIP-qPCR analysis
Input and ChIP DNA fractions were diluted fivefold for use as qPCR templates.
Duplicate 20 µl reactions contained 10 µl of BioRad iTaq Fast SYBR Green supermix
with ROX (Cat no#172-5101), 4 µl of template, 4 µl of 300 nM primer mix and 2 µl of
distilled water. Amplification was performed using a Stratagene Mx3000P Real-Time
PCR system by initial denaturation for 3 min at 95˚C and 40 cycles of denaturation
(95˚C, 3 sec), annealing (55˚C, 30 sec) and extension (72˚C, 30 sec). Data analysis
was done by the ∆Ct method (LIVAK and SCHMITTGEN 2001; SABIOSCIENCES 2008).
Input Ct values were corrected for dilution (Ct

[dilution corrected Input]

= Ct

[Input]-

Log2 (Input

Dilution Factor)) where Input dilution factor = (fraction of the input chromatin saved)-1.
Ct values from ChIP were normalized to the dilution corrected Input DNA Ct values (∆Ct
[normalized ChIP]=

Ct

[ChIP]-

Ct

[dilution corrected Input]).

Normalized ∆Ct values were converted to

percent of Input (% Input = 2 -∆Ct [normalized ChIP] ). Genes tested are in Appendix Table 2.

78

APPENDIX F
qRT-PCR data analysis
Data analysis was done by efficiency corrected comparative quantitation method
(PFAFFL 2001; AGILENT 2012). For each assay (gene) Ct values from biological and
technical replicates were averaged for calibrator (control template) and unknown (test
template). Average Ct values from the unknown were subtracted from the calibrator for
each assay to obtain ∆Ct values (∆Ct[assay] = Ct[Calibrator] - Ct[Unknown]). The ∆Ct values for
each assay were corrected for primer efficiency [Eff. corr. ∆Ct[assay] = (2 + [% E/100])∆Ct)
where % E is primer efficiency percentage ( % E for Dmn=98.5)]. Expression of all
assays was normalized to Dynamitin (Dmn) and yantara (ytr), two euchromatic
autosomal genes that are unchanged in roX1 roX2 mutants (DENG et al. 2009).
Efficiency corrected ∆Ct[Assay] of Dmn and ytr were averaged to obtain normalizing assay
efficiency corrected ∆Ct value (Eff. corr. ∆Ct[Norm.

Assay]).

All assays (Gene Of Interest,

GOI) were normalized to obtain relative quantity value (RQ) = Eff. corr. ∆Ct[GOI] / Eff.
corr. ∆Ct[Norm.

Assay].

Relative quantity values were converted to logarithmic values to

obtain logarithmic fold change values FC = Log2(RQ).
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Normalization to single normalizing gene

CtGOI (calibrator) –CtGOI (unknown)
2+

% Eff.GOI
100

RQ =
CtNorm (calibrator) –CtNorm (unknown)
2+

% Eff.Norm
100

Normalization to more than one normalizing gene

CtGOI (calibrator) –CtGOI (unknown)
2+

% Eff.GOI
100

RQ =
CtNorm (calibrator) –CtNorm (unknown)
Average

2+

% Eff.Norm
100

Eff = primer efficiency, GOI= gene of interest, Norm = normalizing gene, calibrator =
control, unknown = test, RQ= relative quantity
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APPENDIX G
qRT-PCR normalization with MxPro software
1. Open qRTPCR data (.mxp file extension) using MxPro (version 4.10 or higher)
software.
2. Go to File>Convert to new experiment type and choose Comparative
quantitation (Calibrator) and click Convert and click Finish after conversion.
3. Click on Setup.
4. Select all the wells of control templates and choose Calibrator in well type. Under
Collect fluorescence data choose ROX and SYBR. Under reference dye choose
ROX.
5. Select all the wells of test templates and choose Unknown in well type. Under
Collect fluorescence data choose ROX and SYBR. Under reference dye choose
ROX.
6. Identification of Replicates: For test and control, identify which ones are biological
replicates and technical replicates. For a given assay (gene tested) select all
biological replicates including their technical replicates and give them one number.
By doing so you are averaging all the biological and technical replicates for the
analysis.
a. Select gene 1, calibrator biological and technical replicates and give them
Identify replicates>Replicate symbol> 1 or (any number).
b. Click on Auto increment and choose for the same gene, unknown biological
and technical replicates as 2 or (next number).
c. Finish giving replicate symbols to all the genes.
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7. Assign Assay names: Here each assay (gene) will be given its name.
a. Select one gene from both calibrator and unknown.
b. Click on Assign Assay names> a new window opens up. In it under Assign
assays within selected walls> next to SYBR click on Assay> type the gene
name>click on Assay color and assign a color.
c. Repeat the above steps for all genes.
8. Select Normalizing gene: Choose the assay (gene) that will be used as
normalizing assay. Under Setup>Normalizing assay> scroll down and choose the
gene name. If assay name was not assigned then it will show SYBR. In that case
assign assay name first. In case of using two genes for normalizing, after finishing
first gene, select the second gene and repeat the above process. By selecting two
genes as normalizing assays, both genes will be averaged and used for
normalization process.
9. Now select all the calibrator wells and assign assoc. symbol by going in to Identify
associations>Assoc. symbol: A.
10. Repeat the above process for unknown wells by choosing Assoc. symbol B.
11. Now click on Analysis>Analysis Term Settings (including amplification
efficiencies).

In the new window under Active settings> amplification

efficiencies>Efficiency(%) enter primer efficiency values. Note: Due to some
software glitch you can only input primer efficiency values for 5 genes. If you have
more than 5 genes, first finish 5 genes, after finishing analysis for first 5 genes, go to
SetUp,

and remove assign assays for the genes that were analyzed already

82

except normalizing gene. This will turn all those genes into SYBR under Analysis
term settings. For rest of genes, enter efficiently values.
12. Now click on Results>Relative quantity chart.
13. To download this chart go to File>Export chart data>export chart data to
Excel>Format1. vertically grouped by Plot.
14. An excel spread sheet will appear with all the values and graph. Save this excel
sheet as Excel format (.xlsx).
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APPENDIX H
Generation of box plots using R:
Download the most recent version of R (www.r-project.org). The R FAQs and the R
installation and administration manual contained detailed instructions for installing R on
various platforms (Linux, OS X, and Windows). Start R program. Create a comma
delimited (CSV) file that contains gene name (Gene), gene group number (Group) and
logarithmic fold change value (LogFC). Save this file in CSV format into R working
directory (example.csv).
Gene

Group LogFC

Gene1 1

0.153157

Gene2 1

0.19452

Gene3 2

0.077243

Gene4 2

0.04584

Gene5 3

-0.97143

Gene6 3

-0.99124

Gene7 4

-0.59946

Gene8 4

-0.35247

File:example.csv

Using following script, create a boxplot.
example<-read.csv("C:/Documents and Settings/R working directory/example.csv")
#Note: Based on your computer, path to R working directory will be different.
boxplot (LogFC ~ Group, data=mut1, col=0, boxwex=0.4, lwd=3)
Save boxplot as PDF or TIFF file.
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APPENDIX I
Primers used for ChIP-qPCR analysis.
Primer
name

Primer
orientation
F/R

Primer sequence

Dmn

F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

AGATTGAGCAGAAGCAGGGA
CAGCAGCTCCTTGTTGTTCA
CACAGCCTAGTGCAACGGTA
CATGTACTCCAATTGCACCG
CATACTGGGCTCTCCCACAT
CTCGTCAAAGTTGCTCTCCC
GTCGCTTCTTGGATGTCGAG
CTGCGAGTTGTTGCTGTTGT
AAATTAACCTCGCCCTGCTC
ACGGCGACCTTAAGTCCTTT
GGAACGATGAAACCGAGAAA
ATAATGGCCGAGACTTGACG
CCCGTGAAGTTTGACTACGC
TGGTCAGGTCCAAGGGATAG
GCAATTGGAACGAATTTGGA
GAACTGCATGAATGCGAAAA
AAAGCAGCGATTGGCTTTTA
TAGGATGGCGCAGCTCTTAT
TGAGAATACCATCGTGAGCG
GGCTGTCCGGAAGATATTGA
TTGGACTTGTTCAAAAGCGA
TGTGTGGTGCGACTCTTTTC
AGCTGTACGTGCCAGGAAGT
TTTCGATGCATAGCTGGTTG
TTCATCATCATTTTCGCTGG
TTGAACTCCTGTTTGCTGGA
AAGCGGAACATGAGGTTGAC
GCGTTACCCACTTTCGATGT
TGCTATAAGCGCCCTCAAGT
TTGCTCGCTAATTGGAGCTT
TCACTCCAGTCCAGCTGTTG
AATCGTACTTCACGCTCGCT

ytr
Xbp1
GprK2
CG8173
PAR-6
Ucp4A
roX2
plexA
Plex B
Mav
Ephrin
Cals
Rfabp
Eph
CG41099

Primer
working
Conc.
(nM)
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300

Chromosome group

2 and 3 euchromatic
2 and 3 euchromatic
2 and 3 euchromatic
2 and 3 euchromatic
2 and 3 euchromatic
2 and 3 euchromatic
2 and 3 euchromatic
2 and 3 euchromatic
X-linked
X-linked
X-linked
X-linked
X-linked
X-linked
X-linked
X-linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
4th linked
2 and 3 Hetero
2 and 3 Hetero
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Primer
name

Primer
orientation
F/R

Primer sequence

CG17683

F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

AAACCATGTCGAGGTTGAGC
AACCTGTGAGGGCGTAATAAAA
CATCTTTGCAATCAACAGCC
TGCTCACGTCTCAAAGTTGTT
CCATACTTGTGTGACGAACGA
CCTGATTGGAAATTTTACTGACG
ATGGATGGAAGGGCTTTACC
GCCTTGCAGATCCAGAAGTT
TTACCTGATTAACGGTGTCTTGC
TAAAATGGCGGATCGGCTTA
GATCTGGTTGGCAGCACATT
TTTGGTTGCAAAATCCCTTC
TGCATACTTACCCAAAACTTCG
TGGAAAAAGAAGGCGAATTG
TATCGTCATTCCATCGGTCA
AAATGAAAAGGCTGGGACAA

CG17665
CG40439
Spf45
MED21
Rad21
Gprk1
CG12547

Primer
working
Conc.
(nM)
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300
300

Chromosome group

2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
2 and 3 Hetero
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ABSTRACT
THE MECHANISM OF REGULATION OF AUTOSOMAL HETEROCHROMATIC
GENES IN DROSOPHILA MELANOGASTER MALES BY roX RNA AND MSL
PROTEINS
by
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Degree: Doctor of Philosophy
In humans and flies, males and females have different set of sex chromosomes
contributing to different levels of X-linked gene expression. To equalize X-linked gene
dosage between sexes, both humans and flies developed independent strategies which
are called dosage compensation. Human females randomly inactivate one of their X
chromosome into barr body and Drosophila males up regulate their single X
chromosome two fold. Both strategies equalize of X linked gene dose between sexes.
In Drosophila, dosage compensation is brought about by the ribonucleoprotein
Male Specific Lethal (MSL) complex that binds hundreds of sites along the X
chromosome and modifies chromatin to facilitate transcription. Loss of roX RNA, an
essential component of the MSL complex, reduces expression from X-linked genes.
Surprisingly, loss of roX RNA also reduces expression from genes situated in proximal
heterochromatin and on the small, heterochromatic 4th chromosome. Reduction of roX
function suppresses position effect variegation (PEV), revealing functional alteration in
heterochromatin. The effects of roX mutations on heterochromatic gene expression and
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PEV are limited to males. We proposed that roX and some MSL proteins have an
additional role in regulation of heterochromatic genes.
Microarray analysis of male larva that are mutant for MSL2, a male limited
member of the MSL complex, showed that MSL2 is not required for heterochromatic
gene regulation, revealing that intact MSL complex is not required for heterochromatic
gene regulation. Examination of remaining MSL proteins using qRT-PCR showed that
MSL1, MSL3, MOF and MLE, but not Jil-1 kinase, contribute to heterochromatic gene
expression.
To determine if different regions of roX1 are required for dosage compensation
and heterochromatic silencing, examination of both processes with a panel of roX1
deletions showed that roX1 functions are partially separable by some mutations and
roX1 has regions that are required for its heterochromatic function, but not for dosage
compensation.
Chromatin immunoprecipitation of staged embryos revealed that MSL3 binds to
autosomal genes, and to genes in heterochromatic regions, prior to the onset of dosage
compensation, suggesting a direct role at these sites. These findings support the idea
that several MSL complex members participate in additional complexes that target
distinct sets of genes.
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